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ABSTRACT

IDENTIFICATION AND CHARACTERIZATION OF DETERMINANTS OF HEAD
AND NECK TUMOR CELL INVASION

Yangguan Wu
Eastern Virginia Medical School
and Old Dominion University, 1999
Director: Dr. Kenneth D. Somers

Head and neck squamous cell carcinoma (HNSCC) is a common malignant
disease with poor prognosis. The majority o f patients die from local invasion or
lymphatic metastasis. The mechanisin(s) underlining the invasiveness o f HNSCC are
poorly understood. Utilizing a panel o f HNSCC cell lines previously established in our
laboratory, we tested the application and relevance o f the three-step hypothesis o f tumor
invasion to HNSCC and investigated the mechanism(s) pertaining to the regulation of
each step in the invasive process.

Data presented in this thesis demonstrated that tumor

cell invasion in HNSCC is a complex process involving three repeated sequential steps:
adhesion, proteolytic degradation o f the basement membrane and other extracellular
matrixes (ECMs), and cell migration. These three steps are linked and interdependent.
For example, cell adhesion to the ECM triggers a series o f signal transduction pathways
that involve calcium mobilization, focal adhesion kinase (FAK) activation, and
downstream events leading to alteration o f cell function manifested by migration and
matrix metalIoproteinase (MMP) production. Our working model extends the previous
three-step hypothesis for tumor invasion by underscoring FAK as an integrator of
multiple signaling pathways. Efforts to determine the role o f FAK in the integration and
propagation o f signal transduction pathways should lead to a better understanding o f the
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molecular mechanisms for generating the invasive phenotype o f HNSCCs which may,
turn, lead to the discovery o f new targets for therapy o f invasive HNSCC.
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CHAPTER I
INTRODUCTION

Head and neck squamous cell carcinoma is a common malignant disease. Nearly
42.000 new cases o f HNSCC and approximately 13,000 HNSCC deaths are estimated in
the United States in 1998 (1). Globally. HNSCC accounts for 500.000 new cases annually
and is the fifth m ost frequent cancer overall, comprising I o f 12 total malignancies.
Despite improvements in current therapies, including surgery, radiation, and conventional
chemotherapy, 5-year survival rates are low and have remained unchanged over the past
20 years in whites but have decreased in African Americans (1-3). The major obstacle for
the management o f HNSCC is local-regional invasion and lymph node metastasis (3).

1.1 Overview o f the metastatic process

Metastasis is the spread o f tumor from a primary lesion to distant sites o f the body and
represents the hallmark o f tumor malignancy. Successful metastasis formation involves
multiple sequential steps (Fig. 1-1). At the cellular level, tum or cells initiate metastasis by
detachment from the primary tumor and invasion o f the surrounding extracellular matrix
(ECM), including the basement membrane and interstitial compartment, followed by
intravasation o f the nourishing blood vessels or draining lymphatic vessels. Cells are
then carried in the circulation until lodging in a distal capillary bed. The survivors o f the
arrested cells then extravasate from the blood vessel, invade the surrounding tissues and
The journal model for this thesis was Clinical Cancer Research.
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begin to proliferate and form secondary tumors in the new organ environment (4).
Angiogenesis. the recruitment o f new blood vessels, is required for primary' and
metastatic tumors to grow to a clinically detectable size since the solid tumor never grows
beyond 1 mm3 due to lack o f nutrition. Tumor-induced angiogenesis not only allows for
expansion o f the primary tumor, but also permits easy access to the vascular compartment
as a result o f defects in the basement membrane o f the newly formed vessels. Thus,
angiogenesis may facilitate hematogenous spread o f some tumors (5.6).

A ngiogenesis

Local invasion

°
C arcinom a
in situ

\

••

Intravasation

C linical detectable
M etastasis

(EXZD
^

Initial
grow th

K m u k
__
Local
m igation

^

0

S urvival in
circulation

A rrest in
new organ

F ig l-I. M ulti-step cascade o f tum or cell m etastasis.

Many o f the steps in metastasis formation require specific interactions of tumor
cells with the extracellular matrix and the nature and degree o f these matrix interactions
will vary from step to step during the metastasis process (7,8). Escape o f tumor cells from
the primary tumor may require
However,

decreased adhesion to the tumor or stromal matrix.

cell arrest in the target organ that results in tumor-specific patterns o f

R e p ro d u c e d with perm ission of the copyright owner. Further reproduction prohibited without permission.

metastasis formation may be mediated by specific tumor-endothelial interactions and
selective binding to specific matrix components. Only the metastatically competent cells,
which exhibit different responses to various ECM and stromal cells, will successfully
navigate each o f these interactions (7,8). Metastasis is known to be an inefficient process.
Both clinical observations and experimental studies have demonstrated that

large

numbers o f tum or cells are shed into the blood circulation, but only a small fraction o f the
cells succeed in forming metastases (9). One o f the m ajor contributors to this inefficiency
is thought to be the traversal o f the connective tissue barrier, an active process that is
mediated by a specific cell-ECM interactions. Therefore, metastasis can be viewed as a
process o f selection o f cells exhibiting invasive behavior characterized by their tendency
to cross tissue boundaries and a subsequent growth advantage over normal tissue. To
support this point, studies have demonstrated that individual metastases are likely to be
clonal in origin (10).

1.2 The invasive phenotype: A three-step hypothesis

Tumor invasion is a complex and important process and marks the beginning o f
metastasis. It has been proposed that tumor invasion involves three sequential steps: cell
adhesion, proteolytic degradation o f the ECM, and cell migration through the ECM
tunnel created by enzymatic proteolysis (Fig. 1-2) (11). The invasive process o f tumor
cells shares many characteristics similar to normal physiological processes. Attachment,
proteolysis, and migration are steps in trophoblast implantation, mammary gland
involution, embryonic morphogenesis, and tissue remodeling. The difference between

R e p ro d u c e d with perm ission of the copyright owner. Further reproduction prohibited without permission.

4

normal physiological processes and the pathological process o f tum or cell invasion lies in
its regulation. Physiological processes are usually tightly regulated and self- limited.

A ttachm ent

4

T u m o r cell
Endothelial cell
B asem ent m em brane
Strom a

Local proteolysis

4
M igration

Fig. 1-2 Three step hypothesis o f invasion.

whereas tumor invasion is unrestricted relative to the benefit o f the host (12). Basement
membrane is a special kind o f ECM upon which a variety o f cell types including
keratinocytes in skin and endothelial cells in blood vessels rest. It serves as the tissue
barrier at multiple key points in the metastatic cascade, namely, escape from the primary
tumor in carcinoma, intravasation and extravasation during hematogenous dissemination,
and perineural and muscular invasion. Thus, tumor invasion o f the basement membrane
was thought to be the rate-limiting step in metastasis. Composed o f a dense meshwork o f
collagen type IV, laminin, and proteoglycans, the basement membrane does not normally
contain pores that would allow passive tumor cell migration. Therefore, traversal o f the
basement membrane requires an active process defined by the invasive phenotype o f
tumor cells that is dominated by the ability o f tum or cells to attach to, degrade, and
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migrate through the ECM (reviewed in 13). In past decades, increasing interest was
focused on deciphering the m olecular mechanisms underlying the invasive process. The
proposed three-step hypothesis has received extensive experimental support and has
elucidated molecular events related to each step o f tumor invasion and subsequent
metastasis formation (13). However, the step-wise process o f invasion has not been tested
systematically in the context o f HNSCCs. We propose to test the application and
relevance o f this model to HNSCC. To do this, cell adhesion to ECM proteins,
matrix metalloproteinase (MMP) production, chemoinvasion, and cell migration will
be assessed utilizing HNSCC cell lines developed in our laboratory. (Aim 1, Fig. 17.1)

1.3 Cell adhesion and biological consequences

Cell adhesion including cell-cell and cell-ECM adhesion represents the most
direct form o f tumor cell-host interaction. The capacity of tumor cells to adhere to other
tumor cells, host cells, or components o f ECM could affect multiple steps of the
metastatic cascade. Cell adhesion is mediated by a series o f cell adhesion receptors.
Several families o f cell surface adhesion molecules have been identified, each with
different functions and specificities (14,15) These molecules include the cadherins, the
immunoglobulin cell adhesion molecule (Ig-CAM) superfamily, selectins, and integrins.
Cadherins are calcium-dependent molecules that mediate homophilic cell-cell adhesion.
Three subtypes (E-, N-, and P-cadherins) have been characterized. Loss o f the expression
o f cadherins results in the detachment o f tumor cells from the primary tumor site thus
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facilitating metastasis (16,17). The Ig-CAM superfamily, including N-CAM , I-CAM -1,ICAM-2 V-CAM-1. CEA. and DDC, consists o f divalent cation-independent receptors
that have several repeats o f immunoglobulin-like folds characterized by P-pleated sheets
held together by disulfide bonds. These molecules

mediate both homotypic and

heterotypic cell-cell adhesion (18). Selectins. acting through a terminal calciumdependent lectin domain, are involved in heterotypic cell-cell adhesions between blood
cells and endothelial cells. CD44, a homologue o f cartilage link protein, is

a

transmembrane GTP binding protein with intrinsic GTPase activity and functions as a cell
surface receptor for hyaluronate. Under physiological conditions, m ost members o f IgCAM family, selectin. and CD44

function as regulators o f white blood cell trafficking

and lymphocyte homing, whereas in the pathological process o f tum or invasion, they
determine organ- specific metastasis (19).

Like cell-cell interactions, cell adhesion to the ECM is also accomplished by cell
recognition of ECM proteins via cell surface receptors and represents the initial step in
the process o f tumor invasion (13). The most important cell surface receptors in cellECM interaction are integrins, heterodimers o f a and P subunits that can pair to form
more than 20 unique receptors (20). Different integrin receptors interact with different
components o f the ECM (eg., fibronectin, laminin, collagen type IV) by binding to
integrin recognition sites consisting o f a short linear amino acid sequence, e.g. arginineglycine-aspartic acid (RGD) (21). Integrin binding to the ECM and subsequent clustering
leads to the formation o f focal adhesions - specialized sites o f contact - where integrins
link to intracellular cytoskeletal complexes and bundles o f actin filaments. This complex
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o f proteins piays an important role in modulating cell adhesion and regulating cell shape
and mobility. Studies have shown that integrin-mediated cell-ECM interaction stimulates
numerous complex biological processes including MMP production (22), cell migration
(23-26). and changes in phosphorylation o f a number o f structural and signaling proteins.

a. Integrin-mediated cell EC M interaction regulates cell migration

Several lines o f evidence support the notion that integrin mediated cell-ECM
interaction can regulate tumor cell migration. First, som e ECM proteins including
fibronectin, laminin, and type IV collagen were found to stimulate tumor cell locomotion
(23-26). Fibronectin is a large multidomain glycoprotein in the connective tissue matrix.
Each domain o f the fibronectin molecule is composed o f a set o f type I, II, and III repeats,
which together confer specific binding activities. The central cell binding domain
contains the RGD sequence in repeat IIIio , which is essential for interaction with a
number o f integrins including c d p i, avp3. allb p 3 , and a v p 6 (27). Laminins are cross
shaped heterotrimers composed o f a , P, and y chains, which exist as ten different variants
and can assemble into eleven isoform combinations, lam inin-1 to laminin-11. The RGD
containing sequence is located in the a chain. Apart from RGD, 8 other recognition
sequences were also identified in laminin. These sequences mediate the interaction with
integrins including
composed

a 2 p i , a 3 p i, and a 6 p i (28). Type IV collagen is a polypeptide

o f repeating

hydroxyproline

and

hydroxylysine

residues

that,

when

polymerized, forms a sheet like network which is the fundamental structure o f most
basement membranes. Type IV collagen preferentially

binds to a i p i integrin, however,
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a recognition sequence other than RGD may be required for interaction (29. 30).
Fibronectin. laminin, and type IV collagen either in solution (chemotaxis) or coated on a
solid membrane support (haptotaxis) induced tumor cell migration by a number o f tumor
types (23-26). Secondly, expression o f certain integrins was associated with tumor cell
motility.

Studies have shown that expression o f integrins a 2 p i. a 3 p i and

a6pi

correlated with invasive potential and cell motility o f melanoma tumor cells. Moreover,
anti-pi

monoclonal antibody inhibits melanoma cell migration (31).

Similarly,

expression o f a 3 p i was found to be associated with cell migration o f malignant glioma
(26). and

expression o f a 6 p i

is essential for migration o f breast carcinoma

since

knocking out a6 p I by a dominant deletion mutant reduced the motility o f breast cancer
cells (32). Third, disruption o f integrin mediated cell-ECM interaction inhibits tumor
migration.

The synthetic RGD containing peptide, which blocks integrin-Iigand

interaction, successfully inhibits melanoma cell

migration, and subsequently inhibits

tumor invasion. However, relative high concentrations (1 mg/ml) are required to achieve
these effects (33). Similarly, dysintegrin, a RGD containing peptide, obtained from snake
venom, was found to have similar inhibitory activity (33).

b. Integrin mediated cell-ECM interaction regidates MMP production

Like cell migration, ECM proteins were also found to stimulate MMP production.
Incubation o f ovary carcinoma cells in soluble fibronectin increased MMP-9 production
by two-fold (34). Fibronectin was also found to stimulate MMP production by fibroblasts.
Exposure o f osteogenic sarcoma cells to type I collagen induced elevated secretion o f
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MMP-1 (35). Similar to ligand stimulation, cross-linking integrin receptors also increases
MMP production. For example, antibody cross-linking o f integrin a v p 3 enhanced MMP2 production by melanoma cells (36). Taken together, accumulating evidence supports the
concept that integrin mediated cell-ECM interaction regulates MMP production.

Although substantial evidence supports the notion that cell migration and MMP
secretion were regulated by integrin mediated cell-ECM interaction in other cell types,
little is known about cell binding to ECM proteins and promotion o f gene expression and
cell migration o f head and neck tumor cells. We hypothesize that MMP production
and cell migration o f HNSCC are regulated by cell-ECM interactions and propose
to test this possibility by evaluating the alteration of MMP production and cell
migration of HNSCC following exposure to ECM proteins. (Aim 2, Fig. 1-7.2).

1.4 Proteolvtic degradation o f the ECM

Breachment o f the basement membrane and proteolytic degradation o f the ECM
is thought to be a rate-limiting step in tumor invasion (13, 37-39). Tumor cells employ
proteases to accomplish this key step. Four families o f proteases have been implicated in
tumor invasion:

(a) cysteine proteases (eg., cathepsin B,L), (b) aspartyl

proteases

(cathepsin D, E), (c) serine proteases (eg., urokinase-type plasminogen activator), and (d)
matrix metalloproteinases (MMPs). However, much o f the attention has centered on the
MMP family.
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a.

M MP fam ily

MMPs are members o f a increasing fam ily o f Zn2+-dependent endopeptidases
characterized by secretion as a zymogen, activation achieved by proteolytic removal o f
the propeptide, function extracellularly at neutral pH, and inhibition by a specific class o f
biological inhibitors referred to as the tissue inhibitors o f metalloproteinases (TIMPs)
(40). Structurally, MMPs contain the following basic domains: a signal sequence; a

Furin cleavage
d V d g C dsite
T ransm em brane domain
3<S^MT(stromelysin-3<S^
M T-M M P) H inge region
(M T -M M P)

/

/

E
Signal

Pro

C atalytic

Hemopexin

G elatin binding
A ctivation Locus

M etal atom -binding dom ain

PRCGXPD

VAAHEXGHXXGXXH

Fig. 1-3 D om ains o f the m atrix m etalloproteinases (rev ie w ed in 41). E ach m em ber o f the M M P
family has a t least four d o m ain s (1). T h e signal se q u e n c e directs the translation production to
the endoplasm ic reticulum : (2) T he p ropeptide d o m a in th at is lost fo llo w in g enzym e activation.
(3) T he catalytic dom ain th at co n tain s the co n serv ed sequenceV A A H E X G H X X G X X H in w hich
the three histidine residues co o rd in ate the active site zin c (4) the carboxyl-term inal dom ain that
has hom ology to hem o p ex in and vitronectin, is se v e re ly tru ncated in m atrilysin. or contains a
transm em brane dom ain in M T -M M P . In addition, th e re is a fifth d o m ain th at show s hom ology
to the type II fibronectin repeats th at bind gelatin a n d is found only in gciatinases.

propeptide domain; a catalytic domain containing a zinc-binding site; a 54 amino acid
long proline rich region homologous to the a 2 chain o f type V collagen; and a hemopexin
like carboxyl-terminal domain (Fig. 1-3). C-terminal domains are varied to confer
substrate specificity. N-terminal domains are m ore conserved especially at the following
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regions: the amino-terminal profragment ‘activation locus’(PRCGxPD) and the catalytic
domain o f the zinc binding site (HExGHxxHS/T) (40,41) . Three histidines in the
conserved catalytic sequence complex with Zn atoms to form the active site, whereas a
free cysteine in the propeptide m otif binds to the same Zn atom and maintains latency o f
MMPs. Activation is achieved by dissociation o f the propeptide from the catalytic
domain. This dissociation represent a fundamental process for regulation of MMP
activity. MMP activation can be achieved by auto-activation and by the action o f other
proteinases such as furin. urokinase, and plasmin (42). Activation o f M MPs is subject to
regulation by association with TIMPs, and once activated, may be inactivated by TIMPs
and other plasma proteins such as a2-macroglobulin. Thus, the level o f ECM degradation
reflects a local balance o f M MP expression and activation versus the level o f TIMPs. The
four different TIMPs

identified so far are expressed in different tissues and exhibit

different specificities to complex and inhibit MMPs (41-43). Cell surface localization o f
MMPs may achieve a highly regulated focus o f activity while widespread degradation
may result from over-expression o f unchecked secreted MMP. These features o f the
MMP axis are significant in studying their contribution to both normal and pathological
remodeling o f tissues (41-44).

To date, there are 20 members o f MMPs divided into six classes according to their
substrate specificity and internal homologies: (a) the interstitial collagenases which
degrade fibrillar collagens including type I. II, and III collagen; (b) the gelatinases which
degrade denatured forms o f collagen ( gelatin) and type IV collagen, the main form o f
collagen in basement membrane; these MMPs also degrade type V, VII, IX and X
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collagens and fibronectin; (c) the stromelysins which have broad substrate specificity and
degrade various components o f the ECM including fibronectin. laminin and the core
protein o f proteoglycans; (d) elastases which degrade elastin: (e) stromelysin-3 which
targets alpha-1-antitrypsin, and (f) membrane type (MT) MMPs. The last two groups are
distinguished by the insertion o f a furin cleavage site, RXKR, between the prodomain and
catalytic domain.

Presence o f this domain is important for the intracellular activation.

Most MMPs are secreted while MT-MMPs have been shown to be membrane associated
via a transmembrane domain at the carboxyl terminus o f the molecule (41,42).

b. Multilevel regulation o f MMP-2 and MMP-9

MMP-2 and MMP-9 are two well characterized forms o f type IV collagenases
(gelatinases) which share four common domains: the amino-terminal and zinc-binding
domains shared by all members o f the MMP family, a collagen-binding fibronectin-like
domain, and a carboxyl-hemopexin-like domain. The main structural difference between
MMP-2 and MMP-9 is the presence o f a unique proline-rich domain homologous to the
a2-chain o f type V collagen in the hinge region o f MMP-9 (13). MMP-2 is secreted as a
72 kDa proenzyme which is activated

by a recently identified membrane type-MMP

(MT-MMP) to generate 62 kDa, 59kDa and 41-45 kDa active species(45,46). MMP-9 is
secreted as a 92 kDa proenzyme and activated by plasmin, stromelysin, tissue kallikrein,
and MMP-2 to generate a 82 kDa active species ( Fig. 1-4) (47). Activated forms o f
MMP-2 and MMP-9 are capable o f digesting

mainly gelatin and type IV collagen.

Therefore, MMP-2 and MMP-9 are also called 72 kDa type IV collagenase (or gelatinase
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A) and 92 kDa type IV collagenase (or gelatinase B), respectively. Both latent and active
forms o f MMP-2 and MMP-9 can interact with TIM Ps (48). TIMP-1, a 28 kDa
glycoprotein initially isolated from rabbit bone and human fibroblasts, forms a stable
complex with proMMP-9 and blocks the activation o f M MP-9 by stromelysin (49. 50).

MMP-9

ECM

ECM

Cytoplasm ic M embrane
Cytosol

Gogi

Fig. I -4 Activation o f gelatinases on the cell surface. T IM P , tissue inhibitor o f
m etalloproteinase; T B P TIM P-2 binding protein: uPA R . urokinase type plasm inogen
activator receptor: uPA urokinase type plasm inogen activators: PAIs: plam inogen
activator inhibitors; PLG. plasm inogen; X indicats inhibition o f the process.

TIMP-2 is a 21 kDa nonglycosylated protein that shows 66 percent overall homology to
TIMP-1. TIMP-2 can form a complex with proMMP-2 and inhibits MMP-2 activation
(51. 52). Both TIMP-1 and TIMP-2 can form a tight 1:1 stoichiometric noncovalent
complex with MMP-9 and MMP-2, respectively (53). Formation o f TIMP-MMP
complexes

inhibits MMP activity and prevents autoproteolytic degradation o f MMPs.

thus maintaining their integrity and substrate specificity (54).
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Recent studies demonstrated that inhibition o f MMP-2/MMP-9 is mediated by
interaction between the N-terminal region o f MMP and the inhibitory

TIMPs.

Interestingly, the C-terminus o f TIM P-2. and only TIMP-2, was found to also interact
with the C-terminus o f proMMP-2. However, this interaction does not inhibit MMP-2
activity: instead, it is important for proM M P-2 activation. C-terminal TIM P-2 interacting
with proMMP-2 and subsequent binding to a TIMP-2 binding protein

o r MT-MMP.

anchors the proMMP-2 to the cell surface in close proximity to M T-M M P which is
activated intracellularly by a serine protease, furin. The intimate relationship between
active

MT-MMP and proMMP-2 significantly increases the efficiency for MMP-2

activation (Fig. 1-4). Therefore, the effect o f TIMP-2 on MMP-2 is paradoxical. At low
concentrations, it stimulates MMP-2 activity, whereas at high concentrations, it inhibits
MMP-2 activity. Pericellular activation o f MMP-2 is a good example o f spatial regulation
(41).

MMPs are also subject to transcriptional regulation. Transcriptional regulation o f
MMP-2 and MMP-9 is different due to unique elements within each promoter. MMP-2.
whose promoter lacks an AP-1 site, was found to be constitutively expressed in a wide
range o f tissues, whereas expression o f MMP-9 can be stimulated by a variety o f growth
factors, cytokines and ECM proteins in different cell types (43). M ultilevel regulation o f
MMP-2 and MMP-9 is biologically significant. Since

MMP-2 and M M P-9 play

important roles in both physiological (e.g angiogenesis) and pathological matrix
remodeling (e.g tumor invasion), multilevel regulation o f MMP-2/MMP-9 allows precise
control o f MMP activity under physiological conditions. However, excess production and
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activation o f MMP or downregulated TIM P is thought to be a key feature o f the
pathological process, notably tumor invasion (42).

c. MMP-2/MMP-9 and tumor invasion

The role o f MMP-2/MMP-9 in tumor invasion is well established. Secretion of
MMP-2/MMP-9 is correlated with the invasive and metastatic phenotype o f several
tumor types (55-57). Inhibition o f the expression or activity of gelatinases by the synthetic
MMP inhibitor (batimastat), conserved M M P peptide sequences. (58-60) or by a
ribozyme directed against MMP RNA (61)

leads to reduced invasive and metastatic

capacity. The role o f MMP-2/MMP-9 in tumor invasion and metastasis is further
supported by recent clinical studies. Increased gelatinase A (MMP-2) activity was found
in invasive tumor regions o f micro-dissected human colon cancer samples as compared
to a matched number o f normal epithelial cells from the same patient (62). Consistent
with this result, immunohistochemical studies have shown that most invasive colonic
and gastric adenocarcinomas or desmoplastic stroma are immunoreactive for MMP-2.
whereas benign proliferative disorders o f the breast and colon, and normal colorectal and
gastric mucosa, show decreased or negative staining for this enzyme (63-66). Recent
studies using a combination o f immunohistochemistry and zymography demonstrated
that not only expression o f MMP-2/9 but, more importantly, activation o f MMP-2 was
associated

with tumor invasion

and metastasis o f gastric, cervical and endometrial

cancer (67.68). In contrast to MMPs, decreased TIMP expression has been asociated with
invasive tumors (69,70). Exogenous TIMP-1 has been shown to inhibit in vitro tumor cell
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invasion o f human amniotic membranes and in vivo metastasis in animal models (71.72).
Do\vn-regulation o f TIMP-1 expression by transfection o f antisense RNA into mouse
3T3 cells enhanced their ability to invade human amniotic membranes and to form
metastatic tumors in athymic mice (73). TIMP-2 has also been shown to successfully
inhibit in vitro tumor invasion o f the ECM (74). Overexpression o f TIMP-2 in invasive
and metastatic Ras-transformed rat embryo fibroblasts resulted in suppression o f the
ability o f these cells to form lung colonies following intravenous injection into nude mice
(75). An increased ratio o f MMP to TIMP has been detected in cervical cancer and
stroma by in situ RT-PCR and found to correlate with poor prognosis (76).

Accumulating data demonstrated that MMP-2 and MMP-9 play an important role
in the invasive process o f a variety o f tumors (55-76).

However, the role o f MMP-

2/MMP-9 in the invasive phenotype of HNSCCs has not been fully explored (67. 77).
Preliminary studies from our laboratory demonstrated that HNSCC cell lines produce
MMP-2 and/or MMP-9 and that secretion o f MMP-2 is associated with Matrigel
invasion.

The results link MMP-2 expression with a more aggressive tumor cell

phenotype (78). To determine if MMP-2 is required for invasion o f HNSCC, MMPspecific antibody was assessed for inhibition of M atrigel invasion and MMP activity.
(Aim 3 Fig.l. 3).

1.5 Signaling pathways in tumor cell invasion and migration

As discussed above, cell-ECM interactions are mediated by specific classes o f
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integrins. Recent studies have shown that integrins not only regulate cell adhesion, but
are also capable o f transducing signals across the plasma membrane (79,80) and
regulating gene expression. To date, many components o f the integrin signaling pathway
have been identified (81.82), but little is known about the precise molecular mechanisms
by which integrin-mediated signal transduction mediates and/or regulates cell migration
and MMP production.

a. Calcium and invasion

Calcium is one o f the important intracellular second messengers. It participates in
cell signaling by binding to specific cellular proteins including calmodulin and protein
kinase C (PKC). Calmodulin is a calcium-regulated protein that is present in all cells.
Although this protein does not have intrinsic catalytic activity, it does regulate other
cellular enzymes such as adenylyl cyclase and Ca2+/calmodulin protein kinase. PKC is a
serine/threonine protein kinase whose activation depends on binding o f calcium and
diacvlglycerol (DAG). Activation o f PKC leads to phosphorylation of specific cellular
proteins in the target cell (83).

The concentration o f cytosolic calcium in a resting cell is approximately 100 nM.
In the endoplasmic reticulum (ER) and extracellular fluids, the calcium concentration is
in the millimolar range. The calcium gradient is maintained by an ATP-dependent
calcium pump. After cell stimulation, calcium levels in the cytosol transiently rise,
enabling this cation to act on several calcium dependent proteins in the cytoplasm (84)
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Integrin stim ulation was found to generate a rise in intracellular calcium. Crosslinking o f or adhesion via integrins has been shown to induce an increase in the
intracellular calcium concentration in platelets with characteristics similar to inositol1.4.5-trisphosphate (IP3)-mediated calcium increases in other systems (85). Ligation o f
av-p3 integrin on osteoclasts triggers mobilization o f calcium in the nucleus (86). whereas
activation o f integrins on endothelial cells results in elevation o f intracellular calcium by
an influx o f calcium through the plasma membrane (87). These findings indicate that
calcium participates in

integrin signaling. Accumulating evidence demonstrates that

calcium hom eostasis and calcium-regulated cellular events are important in the
generation and maintenance o f the malignant phenotype (88). W e speculate that integrin
mediated-calcium signaling may play a role in generating the invasive phenotype o f
HNSCCs.

Recently, work o f others has shown that inhibition o f calcium influx by

carboxyamidotriazole (CAI) attenuates focal adhesion kinase (FAK) phosphorylation and
activation, indicating that mobilization o f intracellular calcium may be upstream o f FAK
(89).

b. FAK and invasion:

Focal adhesion kinase was originally identified as one o f several proteins that
were highly phosphorylated in src-transformed cells (90). Subsequent cloning o f this
protein showed that it was a novel tyrosine kinase which localized to cellular focal
adhesions (91). Focal adhesion kinase becomes phosphorylated upon adhesion o f
Fibroblasts

and

transform ed

epithelial

cells

to

the

ECM.
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phosphorylation is coincident with cell spreading (92). and inhibitors o f cytoskeletal
polymerization

inhibit

FAK

phosphorylation.

Additionally.

FAK

becomes

phosphorylated on tyrosine in response to certain neuropeptides and growth factors,
indicating that FAK may be involved in cross talk between integrin and growth factor
signaling (93).

1. Structure o f FAK

FAK is a member o f a growing family o f structurally distinct cytoplasmic protein
tyrosine kinases consisting o f three functional domains (94). The catalytic domain, which
exhibits most o f the structural hallmarks of typical tyrosine kinases, is flanked by two-

Integrin

Focal Adhesion
Targeting

binding
FAK
Focal ad h e sio n k in ase

|
Y925
G rb2
Binding

Y397
Src Binding

FRNK
FAK related non-kinase

Fig. 1-5 Functional dom ains o f FAK and FRNK (review ed in 94).

noncatalytic domains that exhibit little sequence similarity to other proteins (Fig. 1-5).The
FAK amino terminal dom ain is responsible for integrin binding, while the carboxyl-
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terminal domain mediates direct interaction with the adhesion-associated protein,
paxillin. and targeting to the focal adhesion, defined as integrin-mediated sites o f contact
between the cell and the ECM (94). Unlike many other nonreceptor tyrosine kinases.
FAK lacks Src homology 2 or 3 (SH2 or SH3) domains, which mediate specific
interactions with phosphotyrosine-containing sequences or proline-rich sequences,
respectively (95). Instead. FAK contains consensus sequences that allow proteins with
SH2 or SH3 domains to bind. Two proline-rich stretches, three tyrosine phosphorylation
sites including a m otif (YAEI) for the binding o f Src SH2 domain, a m otif (YMXM) for
the binding o f the SH2 domain o f the p85 subunit o f phosphatidylinositol 3-kinase and a
m otif (YENV) for binding the Grb2 SH2 domain have been identified (96).

2. FAK substrates and signaling

FAK plays a central role in integrin-mediated signaling (Fig. 1-6). Integrins are
receptors for extracellular matrix proteins. Presence o f SH2 and SH3 binding sites in
FAK ensures activation o f downstream events following integrin activation. However, the
mechanism o f FAK activation is poorly understood. Studies have shown protein-protein
interactions between the amino terminal domain o f FAK and the cytoplasmic domain of
the integrin (31 subunit, suggesting that the direct interaction may transduce the signal
generated from integrin -ECM binding (97). Other data suggest that talin is an upsteam
mediator o f FAK (98). Independent o f the mechanism, cell-matrix interaction results in
autophosphorylation o f FAK at Tyr-397 which recruits Src through the SH2 domain (99).
FAK/Src interaction releases autoinhibition o f Src by displacement o f the C-terminal
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regulatory tyrosine residue from the SH2 domain, resulting in Src enzymatic activity.
This interaction is negatively regulated by C-terminal Src kinase (Csk) (100). Activated
FAK/Src then phosphorylates substrates located in focal adhesions including paxillin.
tensin. p l3 0 cas, and cortactin (95) which regulate cytoskeleton assembly. Recently,
phosphorylation o f FAK Tyr-397 was shown to be required for association with PI3ECM
Integrins
<(

frnk)

' C a -'

>■
FAK

Paxillin'

PtdIns(4.5}P2

CSOfr*' V

^

Cortactin
VCSG'

Sos ;
PtdIns<3,4.5)P3

Cytoskeletal
changes

< p^ >
m ig ra tio n
MAPK

Gene
Expression

Fig. 1-6 Integrin signaling p athw ays through FAK. Binding o f integrins to ECM
leads to activation o f FAK and its subsequent association with Src. The FAK/ Src
com plex then triggers several dow nstream pathw ays, leading to altered gene
expression o r cytoskeletalchanges.

kinase (54). PI 3-kinase phosphorylates PtdIns(4,5)P2 to produce phosphatidylinositol
3.4.5-triphosphate [PrdIns(3,4.5)P3], which acts as a second messenger to activate PKC
(101). Tyr-925 o f FAK is phosphorylated by Src and serves as the binding site for the
Grb2/Sos complex. FAK:Grb2/Sos association relays the signal into the nucleus via the
Ras-M AP kinase pathway (102). FAK is expressed in most cell lines and tissues
exam ined to date (98). In some cells, the carboxyl-terminal domain o f FAK is expressed
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autonomously as a 41,000 Mr protein, termed FAK-related nonkinase (FRNK) (103).
FRNK expression is regulated via a separate promoter within an intron o f the full-length
protein [ J.T. Parsons, personal communication]. The function o f FRNK is not clear.
Since FRNK contains the focal adhesion targeting sequence, it is reasonable to speculate
that FRNK may play a role in localization o f FAK to focal adhesion sites and in directing
the binding o f FAK to potential cellular substrates (91). Recently, FRNK was
demonstrated to inhibit FAK phosphorylation and cell spreading following integrin
activation, providing a novel mechanism for FAK regulation (104).

3. FAK and invasion

There are several indications that integrin signaling through FAK m ight be
involved in tumor invasion and metastasis. Overexpression o f FAK has been detected in a
number o f invasive tumors (105,106), and phosphorylated FAK has been linked to the
invasive phenotype and progression o f some tumors (107,108). Fibroblasts cultured from
FAK knockout mice exhibited decreased motility but increased focal adhesion contacts,
suggesting that FAK may play a role in focal adhesion turnover, which promotes
migration (109). The regulation o f cell migration by FAK was further supported by the
demonstration that FAK overexpression in CHO cells resulted in increased migration
towards fibronectin, whereas mutation o f the autophosphorylation site in FAK (Tyr-397)
abolished the migration-stimulating effects (110).

In addition to cell migration, the

integrin-FAK signal transduction pathway is involved in the activation o f MMP secretion.
Down-regulation o f FAK expression by treatment with antisense oligonucleotides to FAK
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attenuated MMP-9 production by ovarian tumor cells (111). W hether FAK is involved
in activation o f MMP secretion and cell migration in HNSCCs has not been
evaluated previously and is one aim of the present studies (Aim 5. Fig. 1-7.5).

1.6 Rationale and focus o f the present studv

Head and neck cancer is a common malignant disease with poor prognosis. The
majority o f patients die o f local or regionally advanced disease. The mechanism(s)
underlying the invasiveness o f head and neck squamous cell carcinoma (HNSCC) are
poorly understood. Previous work from our laboratory has shown that inoculation o f
HNSCC cells into the oral cavity o f nude mice demonstrated tumor growth and invasion
at the orthotopic site, which mimicked the growth and invasive behavior o f human
HNSCC (112).

In contrast. HNSCC cells implanted subcutaneously in the scapular

region o f nude mice formed localized tumors that were totally encapsulated by fibrous
connective tissue (112). The results suggested that the tissue microenvironment and cellECM interactions were likely to be important determinants in regulation o f the invasive
phenotype o f HNSCC.

How cell-matrix interactions and the microenvironment alter the

invasive behavior o f HNSCC remain to be determined. Studies with other cell types have
shown that cell-ECM interaction not only regulates the invasive process but also plays an
important role in generating and transducing signals across the cell membrane (79). Many
signal transduction pathways are activated by cell-ECM interaction (81). A few studies
have suggested that Ca2+ dependent signaling (88) and activation o f focal adhesion
kinase (82) are important in the regulation o f cell motility and tumor invasion. We
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hypothesize that cell adhesion to ECM proteins triggers a series o f signal transduction
pathways that involves Ca2+-dependent signaling, activation o f focal adhesion kinase and
downstream events leading to altered cell function manifested by MMP production and
cell migration (Fig. 1-7).

Cell Function
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Fig. 1-7 Schem atic presentation o f the invasive process o f H N SC C . N u m bers in
circles indicate the specific aim s we propose in this study.

The overall aim o f this thesis is to test the above hypothesis by characterizing
determinants o f the invasive phenotype o f HNSCC and to investigate their role and
involvement in regulation o f the invasive behavior o f HNSCC. Our long-term goal is to
identify intervention targets that might be exploited to control locoregional disease
progression and improve prognosis.

T he specific aims are to: 1. Characterize the invasive phenotype o f FINSCC. Cell lines
derived from HNSCC were assessed for adhesion to ECM proteins, migration, Matrigel
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invasion and production o f MMPs by zymography and immunoblotting. HNSCC cell
lines were further assessed for expression o f selective endogenous inhibitors o f MMPs.
termed tissue inhibitors o f metalloproteinases (TIMPs), by immunoblotting and reverse
zymography.

2. Determine the degree to which MMP production and migration are regulated by cellECM interaction. This was achieved by measuring M MP production by ECM proteinstimulated cells and assessing the effect o f cell attachment to ECM on cell migration by
chemotaxis using ECM proteins as chemoattractants.

The specificity o f this integrin-

mediated interaction was assessed with blocking peptides to adhesive recognition
sequences.

3. Determine the role o f MMPs in invasion o f HNSCC.. Antibody to MMPs was assessed
for the ability to affect Matrigel invasion and MMP activity determined by zymography.

4. Determine the role o f calcium signaling in the regulation o f MMP secretion and
generation o f the invasive phenotype o f HNSCCs.. The role o f calcium dependent
signaling in generation o f the invasive phenotype o f HNSCC was assessed by testing the
effect o f carboxyamido-triazole (CAI), a novel calcium influx inhibitor, on cell migration,
MMP production, and Matrigel invasion.

5. Determine the role o f focal adhesion kinase (FAK) in the regulation o f MMP
production and generation o f the invasive phenotype o f HNSCCs. Specifically, a) FAK
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expression and its activation by phosphorylation in HNSCC cell lines was assessed by
immunoprecipitation and immunoblotting and examined for association with the invasive
phenotype determined by Matrigel invasion, migration and MMP production, b) Sense
FAK or the catalytically inactive isoform, FAK-related non-kinase (FRNK). was
expressed by transfection o f HNSCC cell lines to assess the consequences o f FAK or
FRNK transfection on the invasive phenotype o f HNSCC cell lines.

Sense

FAK is

expected to alter FAK expression, whereas sense FRNK expression is expected to inhibit
FAK phosphorylation due to substrate competition.

Manipulation o f FAK expression

and phosphorylation by transfection o f head and neck tumor cells will assess directly the
effects o f FAK on the invasive phenotype o f HNSCCs.
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CHAPTER II
MATERIALS AND METHODS

2.1 Cell lines and cell culture

HNSCC cell lines derived from carcinoma o f the tongue (EVSCC14M.
EVSCC17M, EVSCC19M) and larynx (EVSCC18) were established at Eastern Virginia
Medical School (113, 114). Additional HNSCC cell lines, UMSCC10A and FaDu. were
derived from SCC o f the larynx and hypopharynx, respectively (114). All HNSCC cell
lines were cultured in EMEM supplemented with 10% fetal bovine serum (FBS) and nonessential amino acids. HaCaT, a spontaneously immortalized keratinocyte cell line (115)
and RHEK-1, an SV40 T antigen immortalized human keratinocyte cell line (116) served
as negative controls. HT1080. a

human fibrosarcoma cell line, and A431

wellcharacterized vulvar carcinoma cell line

were used as

a

positve controls for

invasionand MMP production. NIH3T3 cells were used as a source o f conditioned
medium for migration and chemoinvasion assays. HaCaT, RHEK-1, HT1080, A431 and
NIH3T3 cells were grown in DMEM supplemented with 10% FBS. All cells were
cultured at 37°C in 5% CCV95% air.

2.2 Cell adhesion assay

Adhesion assays were carried out in 96-well tissue culture plates ( Costar,
Cambridge, MA) (117). The plates were coated overnight at 4°C with human plasm a
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fibronectin. mouse laminin, and type IV collagen ( Gibco BRL. Gaithersburg, MD) at
various concentrations. Plates

were then

rinsed three times in

PBS and blocked by

incubation in 0.1% heat inactivated bovine serum albumin (BSA) fraction V (Sigma. St.
Louis. MO) for two hours at room temperature. The cells were harvested by trypsinEDTA (Gibco BRL, Gaithersburg, MD) , washed once with growth medium containing
10% FBS and remained in suspension for 1 hour at room temperature. The cells were
then resuspended in serum-free medium containing 0.1% BSA and added to ECM
protein- coated 96 well culture plates at a density o f 5 x l0 4 cells/well. After 2 hours at
37°C in a humidified atmosphere containing 5% CO 2 , non adherent cells were removed
by rinsing twice in PBS, and the adherent cells were fixed with 10% trichloroacetic acid
(TCA) at 4°C for 1 hour. The plates were then washed five times with tap water to
remove TCA, air-dried, and stained for 30 minutes with 0.4% (wt/vol) sulforhodamine B
(SRB) (Sigma, St. Louis. MO) dissoved in 1% acetic acid (118). A t the end o f the
staining period, SRB was rem oved and the plates were quickly rinsed four times with 1%
acetic acid to remove unbound dye. The bound dye was extracted in 10 mM unbuffered
Tris base [tris(hydroxymethyIaminomethane] (pH 10.5) for 20 minutes on a shaker. The
optical density (OD) was read in a microtiter plate reader at 490 nm. To determine the
effect o f RGD peptides on cell adhesion to ECM. The RGD peptide, GRGDSP or the
control RGE peptide, GRGESP, ( Gibco BRL. Gaithersburg, MD) were added to the
cell suspension at concentrations o f 0.5mM, ImM, 2mM or 4mM 30 min before the assay
was initiated.
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2.3 Chemoinvasion and migration assays

Chemoinvasion and cell migration assays were performed in a 48-well modified
Bovden chamber. Polycarbonate filters (pore size: 8pm, Nucleopore, Cabin John. MD)
were first coated with type IV collagen (5pg/filter) (Gibco BRL. Life Technologies.
Grand Island. New York ) and air dried. Matrigel (lm g/m l) in cold distilled water was
layered onto each filter (500pg/filter). Filters were dried at room temperature and
reconstituted with DMEM. Serum-free NIH 3T3 conditioned medium, obtained by
incubation o f cells for 24 hrs, was used as a source o f chemoattractants unless otherwise
noted. Cells were harvested by trypsinization and suspended in DMEM containing 0.1%
BSA. The chamber was assembled using freshly prepared Matrigel-coated filters and
NIH 3T3 conditioned medium was added to the lower chamber. A 56 pi sample o f cell
suspension (2 x l0 6/ml) was then placed in the upper compartment and incubated at 37°C
in 5% CC>2/95% air for 5 hours. At the end o f the incubation, the cells on the upper
surface o f the filters were mechanically removed. Filters were fixed and stained with
Diff-Quik (Baxter, McGaw Park, IL), and the number o f invasive cells was counted using
a microscope with an image analyzer. Cell migration assays in response to NIH 3T3
conditioned medium were performed similarly in modified Boyden chambers using
polycarbonate filters coated with 0.01 mg/ml gelatin which is permissive for cell
attachment and migration.

2.4 Collection o f conditioned medium

T25 flasks seeded with 2x 106 cells were incubated at 37°C for 24 hrs, washed

R e p ro d u c e d with perm ission of the copyright owner. Further reproduction prohibited without permission.

30

with ITS (insulin, transferrin, selenium; Sigma, St Louis, MO) medium and incubated in
3 ml o f ITS medium at 37°C for 24 hours. The conditioned medium (CM ) was collected,
centrifuged at 400xg for lOmin at 4°C to remove cells and cell debris, and stored at 70°C. For specific experiments, conditioned medium samples were concentrated 10-fold
using an Amicon concentrator 10 (Millipore Corporation, Bedford, MA) which excluded
molecules o f less than 10 kDa.

2.5 Zvmographv

Gelatin zymography was performed as described previously (119) using a mini
gel apparatus (Bio-Rad, Richmond, CA). Briefly, aliquots o f CM (40pl) were loaded
onto 10% acrylamide gels containing 1mg/ml o f gelatin. After electrophoresis, gels were
washed twice for 30 min with 2.5% Triton X-100 and incubated in 50 mM Tris-HCl pH
7.5. 150mM NaCl, 10 mM CaCh , 0.02% Brij-35 and 0.1% Triton X-100 overnight at
37°C. The gels were place in 0.5% Coomassie Blue R 250 dissolved in 40% ethanol and
microwaved at full power for one minute. The gel was further stained in the same
solution for 15 minutes and subsequently destained in three changes o f acetic acidethanol solution (10% acetic acid, 40% ethanol) at 30, 60, 60 minutes intervals. The gels
were stored in 10% acetic acid solution at 4°C. The gelatinolytic activity was visualized
as cleared regions o f the gel and

quantitated by scanning densitometry o f individual

lanes.
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2.5 Reverse Zvmographv

Reverse zymography was also performed on a mini-gel apparatus according to
Festruccia et al (120). Aliquots ( 30 ul) o f lOx concentrated CM were loaded onto 10%
SDS-polyacrylamide gels copolymerized with 1% (wt/vol) o f gelatin

and

EVSCC18 conditioned medium which served as a source o f MMPs.

25% o f
Following

electrophoresis o f samples. SDS was removed from the gel by exchange in 2.5% Triton
X-100 solution which allows MMPs in the gel to renature. The gel was incubated 72 to
96 hours in enzyme buffer (50 mM Tris, pH 7.5, 200 mM NaCl, 5 mM CaCF, 0.02%
Brij-35), stained with 0.5% Coomassie Brilliant Blue R 250 , and destained in ethanolacetic acid as described for zymography.

Areas o f inhibition were visualized as blue

bands on a clear background o f the reverse zymogram.

2.7 Western blot analysis o f MMP-2 and TIMP-2

Monolayer cell cultures (75-80% confluency) were rinsed with ice-cold PBS. and
then solubilized in lysis buffer containing 150 mM NaCl, 50mM Tris, pH 7.5 1% TritonX 100. 0.25% Na-deoxycholate, ImM PMSF, ImM N aV 04, 50 ug/ml leupeptin, 0.5%
aprotinin for 20 minutes on ice. Cells were scraped from the culture vessels, transferred
to 1.5 ml microcentrifuge tubes, and
supemants were

centrifuged for 15 m in at 4°C at 105 x g. The

aliquoted and stored at -80 °C. Protein concentration was measured

using the BCA protein assay kit ( Pierce Chemical Co., Rockford, IL).
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Cell lysates (50ug) or concentrated conditioned medium were resolved by 10%
SDS-polyacrylamide gel electrophoresis (SDS-PAGE). After electrophoresis, gels were
equilibrated in transfer buffer consisting o f 25 mM Tris HCL, 190 mM glycine. 10%
methanol. 0.02% SDS and then transferred to Immobilon P membranes ( Millipore.
Bedford. MA) using a semi-dry electrophoretic transfer cell (Biorad, Richmond. CA).
The transfer was carried out at room temperature for 40 minutes at 18 volts for MMP-2
analysis, or 35 minutes at 15 volts for TIMP-2 analysis. Following transfer, the
m embrane was blocked for 1.5 hours in buffer containing 50 mM Tris (pH 7.5) 150 mM
N aCl. 0.05% Tween 20 and 5 % non-fat dry milk. For analysis o f conditioned medium,
the membrane was

incubated for 1.5 hours at room temperature with 0.5 ug/ml

m onoclonal antibody to MMP-2 or TIMP-2 (Oncogene Science, a gift from Dr. T. Bos).
For analysis o f cell lysates, membranes were incubated similarly with lpg/m l polyclonal
antibody to MMP-2 and TIMP-2, obtained from Dr. Stetler- Stevenson, NCI. After three
w ashes in 50mM Tris, 150 mM NaCl, 0. 01% Tween 20, the membranes were incubated
in a horseradish peroxidase conjugated secondary antibody for one hour. Proteins were
visualized by enhanced chemiluminescence (ECL) ( Amersham, Arlington, Heights, IL).

2.8 Assay for effect o f ECM proteins on cell migration and MMP production

The migration assay was performed in modified Boyden chambers as described
in section 2.3. The ECM proteins, fibronectin, laminin, or type IV collagen at
concentrations o f 1, 10, 20,40, or 80 pg/ml were added individually to the lower chamber
as chemoattractants, with BSA used as a negative control. Chambers were incubated at
37°C and the assays were terminated at 5 hours. Cells on the upper surface were removed
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mechanically, whereas

cells on the lower surface o f the membrane were stained and

enumerated manually under 400 x magnification. The data are represented as the number
o f migrated cells per high power field. To determine the specificity o f cell adhesion to
ECM proteins. 0.5mM to 4 mM o f RGD or RGE peptides were added to the cell
suspension 2 hours before addition to upper chamber, and remained in the upper chamber
during the migration assay.

To assess MMP production, cells (2 x 105 ) were plated into each well of a 24
well tissue culture plate and allowed to attached overnight. Adherent cells were washed
twice with serum-free ITS medium, and treated with ITS medium containing 10. 20. 40.
or 80 pg/ml o f fibronectin, Iaminin, or type IV collagen. Serum-free ITS medium
containing 80 pg/ml o f BSA served as a negative control. Plates were incubated for 24
hours at 37°C.

Conditioned medium was collected and subjected to zymography as

described in section 2.5.

2.9 Assay o f MMP-2 antibody treatment and Matrigel invasion

Matrigel invasion assay was performed as described in section 2.3. Different
concentrations o f affinity purified anti MMP-2 rabbit polyclonal antibody ranging from
12.5 to 100 pg/ml were added to the upper chamber during the 5 hour assay. Normal
rabbit antiserum (200 fig/ml) was added to the upper chamber as a control. The number
o f invaded cells was counted in 5 high-powered fields at 400 X magnification and data
presented as the number o f invaded cells per high-power field.
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2.10 Treatment o f cells with CAI

Carboxvamido-triazole (CAI) was generously provided by Dr. Elise Kohn. NCI.
Bethesda. MD. T75 flasks were seeded with 106 cells in growth medium and cultured at
37°C overnight to allow cell attachment. The next day. cells were washed with PBS and
incubated in growth medium containing various concentrations o f CAI (1 uM to 20 uM)
for 24 hours. Cells were then harvested by trypsinization and chemoinvasion and
migration assays performed as described in section 2.3. CAI was present throughout the
procedure and in the upper and lower chamber during the five hour chemoinvasion and
migration assay.

2.11 Measurement o f intracellular free calcium

Nearly confluent cultures o f cells grown in T75 flasks were serum-starved for 4 hr and
removed by brief trypsinization. Cells were washed and resuspended in phenol red-free
Hanks' balanced salt solution (HBSS) supplemented with 0.1% BSA. fraction V
( Sigma, St. Louis, MO). C ells were loaded with 4 pM o f the calcium indicator dye FuraAM (Molecular Probes, Eugene, OR) for 1 hr at 37°C as described previously (121, 122)
Calcium mobilization was assesssed in Fura-2AM loaded cells using a SPEX ARCM
spectrofluorimeter at 330 and 380 nm. Calcium levels in nanomolar values were
calculated as described previously (122), using calibration in the presence o f CAI to
compensate for any influence o f CAI on fluorescence values.
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2.12 Immunoprecipitation and immunoblotting analysis o f FAK

Immunoprecipitation was performed as described by M atsumoto et al (123). Briefly,
cells (106 ) were cultured in growth medium containing 0.5% FBS for 18 hours. Serum
starved cells were washed with PBS containing 0.1 mM N a3V 04, and lysed in 1 ml o f
modified RJPA lysis buffer consisting o f 50 mM Tris HCL (pH 7.5), 4mM EDTA, 150
mM NaCL. 10 mM sodium pyrophosphate. 10 mM NaF. 1 mM N aV 04, 0.1% sodium
deoxycholate. 1 mM phenylmethysulfonyl fluoride. 10 ug/ml aprotinin. and 1% Nonidet
P-40. Lysates were centrifuged at (105 x g) 4°C and supernatants were aliquoted and
stored at -80°C. Protein concentration was determined as described in section 2.7. and
cell lysates ( 800 pg protein) were precleared by incubation with protein A- agarose for
1 hour at 4°C followed by centrifugation at room temperature at 5000 x g for 5 minutes.
Supernatants were then transferred to fresh tubes and incubated at 4°C overnight with 8
pg o f monoclonal antibody to FAK (2A7, Upstate Biotechnology, Lake Placid. NY).
Immunocomplexes were recovered using goat anti mouse IgG- agarose,

separated by

SDS-PAGE,

probed

and

transferred

to

Immobilon-P.

M embranes

were

with

antiphosphotyrosine antibody (RC 20, 1 pg/ml) to assess FAK phosphorylation or 2A7
antibody (1 pg/ml) to assess FAK expression, followed by incubation with peroxidaseconjugated goat anti-mouse IgG and the immunoreactive bands visualized by ECL.

2. 13 Generation o f FAK and FRNK eukaryotic expression vectors

FAK and FRNK cDNA in Bluescript phagemids were kindly provided by J.T.
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Parsons (University o f Virginia, Charlottesville, VA) and were cloned into the expression
vector pSV.Sport 1 in the sense and antisense orientation. pSV. Sport 1 is commercially
available

eukaryotic

expression

vector

containing

the

SV40

promoter

and

polyadenyaltion signal. It was chosen because o f previously successful experiments in
this laboratory using the vector to express the gene Ems-1/cortactin in fibroblasts (124).
The strategy for construction o f the sense FAK expression vector is shown in Fig. 2-1.
Briefly. pSK. FAK was cut by Xho I , followed by treatment with Klenow DNA

|Sai I. 27
X ho I. 33
t.K p n I.4 8

SV 40
EcoR I
Sm a I
pSV SPORT1
Not I. 2920

Poly A \

X'bal. 2828
B am H . 2940
S m a I. 2946

Xba I
Hmd m
Mu I

M lu I

K lenow

Klenow

FA K
3*

Sticky

?

,jj N ot I ~ P v u I
FAK
™ 3‘

Blunt end

Blunt
-3 I K b

Itgase

(I 22K b - I 6 7 K b) 3 3 Kb

0
Xho

SV40

Polv A

Fig. 2-1 The strategy for construction o f sense FAK expression vector. pSK.FAK is cut
by Xho I, follow ed by treatm ent o f Klenow DNA polym erase to generate 3 ’ blunt ends. The
FAK inserts are obtain ed by restriction digestion with N ot I which gives rise to 5 ’ sticky ends.
Pvu I is added to cu t the vector backbone so that the FAK fragm ent is ea sier to separate from
the vector. FAK fragm ents are ligated to the m ultiple cloning site (M C S) o f pSV . S p o rtl which
has a blunt end n e a r the poly A tail (generated by Mlu I digestion, follow ed by Klenow
treatm ent) and a N o t I sticky end n ear the SV40 prom oter. N ot I sticky ends favor ligation in
the norm al orientation.
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polymerase to generate 3 ' blunt ends. The FAK insert was obtained by restriction
digestion with Not I which gives rise to 5’ sticky ends.
Bluescript vector

so that the

Pvu I was added to cut the

FAK fragment was easier to separate from the vector

backbone. FAK fragments were then ligated to the multiple cloning site (M CS) o f pSV.
Sport 1 which has a blunt end near the poly A tail (generated by Mlu I digestion, follow
by Klenow treatment) and a Not I sticky end near the SV40 promoter. Not I sticky ends
favor ligation in the normal orientation. The ligation mix was transformed into competent
E. coli DH5a by electroporation. Sense FAK expression clones were screened by
restriction digestion with Dral. The strategy to generate the antisense FAK expression
vector. pSV.aFAK, is shown in Fig. 2-2. Briefly, pSK.FAK was cut with Sal I and Xbal.

Pvu L I 706
pSV SPO RT! “ V m c s T
,a\

Poly A

y

Sal 1
N ot- •I
\\b a |

Xba L 2928
Snu I. 29 4 6

X ba I - P v u I
S ticky

’ =

£A

k

i

ii

Xba I
,

( I 22 Kb - 1 67Kb) 3 3Kb

Sal

P"** a ^AK
6 4 Kb

X ba!
Poly A

Fig.2-2 C onstruction o f the antisense FA K expression vector. pSK .FA K is cu t w ith
Sal I and X bal. Full length FA K w ith a 3 ’ Sail sticky end and a 5 ' X ba I end is ligated
to M CS o f pSV . Sport 1. Since the Sal I site is near the prom oter, w hereas the X bal
site is near poly A tail, the ligation favors insertion in the the reverse orientation.

Full length FAK with a 3 ’ Sal I sticky end and a 5’ Xba I end was ligated to the MCS o f
pSV.Sportl. Since the Sal I site is near the promoter, whereas the Xba I site is near the
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poly A tail, the ligation favors insertion in the reverse orientation. The antisense FAK
clone was screened by digestion with Dra I (Fig. 2-2).

Sense and antisense FRNK expression vectors were cloned by EcoR I digestion
o f pSK FRNK followed by ligation to the EcoR I site in the M CS o f pSV .Sportl. pSV.
Sport 1 was treated with alkaline phosphatase before ligation to prevent self-religation and
to improve efficiency. EcoR I released FRNK can be ligated to the EcoR I site in the
MCS o f pSV.Sportl in either orientation. The FRNK clones were screened by Hind III

EcoR I
H in d III
y
V 4°
pSV SPO R T^

pS K F R N K

EcoR I

4142

3160
ou

E coR I

pSV FR N K
4 3 Kb

7/ -p 0|v^AH i n d H I

E co R I
P h o sp h a ta s e

I IK b

S V 40 ,

, EcoR I
/xba

S,V-II
tco R I
H in d III

H in d III

pSV aF R N K
1 EcoR I
P o ly A

4 3 Kb

'

L EcoR I
P o lv A

Fig. 2-3 C o nstruction o f sen se F R N K expression vector. S ense F R N K ex p ressio n v ecto r
is cloned by E coR I d ig e stio n o f pS K .F R N K follow ed by ligation to th e E coR I site in
M CS o f p S V .S p o rtl. p S V .S p o rtl is treated w ith alkaline p h o sp h atase b efo re ligation to
prevent self-ligation and to im p ro v e efficiency. EcoR I released F R N K can b e ligated
to E coR l site in M C S o f p S V .S p o rtl in eith er orientation.

digestion (Fig. 2-3).
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2.14 Transfection

Cell transfection was performed with Fugene 6 reagents ((Boehringer Mannheim.
Indianapolis. rN) according to the manufacturer's instructions. Briefly. 5 x 104 cells were
plated in six well tissue culture plates and grown overnight in growth medium. On the
second day. the medium was replaced with 3 ml o f fresh medium and transfection was
accomplished by dropwise addition o f the transfection mixture onto the cells. Briefly.
10-15 pg o f FAK or FRNK plasmid DNA and 0.5-1 fig o f pSV2neo plasmid DNA or
pSV2neo DNA alone was transfected, using Fugene 6. into recipient cells. Stable
transfectants were selected by growing cells in 400 pg/ml o f G418 (Gibco BRL. Grand
Island. NY). Drug-resistant colonies were picked 15-20 days after transfection and clones
expanded in G418 containing medium for subsequent analysis. Cells transfected with
pSV2neo alone were selected similarly, single cell clones were expanded and used as
controls. Candidate clones were screened to verify FAK or FRNK expression by
immunoblotting with BC3 polyclonal antibody which recognizes epitopes in the Cterminus o f FAK. Selected clones were assessed for the invasive phenotype including
Matrigel invasion. MMP production and cell migration.

R e p ro d u c e d with perm ission of th e copyright owner. Further reproduction prohibited without permission.

40

CHAPTER III
RESULTS

3.11 Matrieel invasion, cell migration, and secretion o f MMP define the invasive
phenotype o f HNSCC cell lines

a. Matrigel invasion and cell migration.

The mechanisms underlying the invasiveness o f head and neck squamous cell
carcinoma are poorly understood (3). Previous studies from our laboratory suggested that
cel 1-matrix interactions play an important role in regulation o f the invasive phenotype o f
HNSCCs (4). To further dissect the molecular mechanisms that regulate the invasiveness
o f HNSCC. we have developed a series o f HNSCC cell lines. Our initial goal was to
characterize the invasive phenotype o f HNSCCs.

To do that, we measured Matrigel

invasion o f HNSCC cell lines by a chemoinvasion assay which measures the capacity o f
cells to penetrate an in vitro reconstituted basement membrane o f Matrigel in response to
chemoattractants.

Six HNSCC cell lines were evaluated. HNSCC cell lines derived from carcinoma
o f tongue (EVSCC14M. EVSCC17M, EVSCC19M) and larynx (EVSCC18) were
established at Eastern Virginia Medical School. Additional HNSCC cell

lines,

UMSCC10A and FaDu, were derived from SCC o f the larynx and hypopharynx,
respectively. HT1080, a human fibrosarcoma cell line, and A431, a well-characterized
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vulvar carcinoma cell line, served as positive controls for invasion.

RHEK-1. an SV40

T-antigen

and

immortalized

human

keratinocyte

cell

line,

HaCaT,

a

spontaneousimmortalized human keratinocyte cell line, served as negative controls.
HT1080 and A431 were highly invasive in the chemoinvasion assay, whereas. HaCaT
and RHEK-1 cells were weakly and moderately invasive, respectively

(Fig. 3.1).

HNSCC cell lines exhibited a range o f invasive potential and were classified as highly
invasive (EVSCC14 M. EVSCC17M) or weakly invasive (EVSCC18. EVSCC19M.
UMSCC10A. FaDu) (Fig.3-1).

Fig.3-1 Matrigel invasion by HNSCC lines. Invasion assays were conducted
with Matrigel-coated 8 pM- pore size polycarbonate membranes in a modified
Boyden chamber and was measured after 5 hours of exposure to 3T3
conditioned medium. Cells on the underside of the membrane were stained
and counted by a image analyzer. Results are means (Bars, SE) of two
independent experiments, with a total of six replicates.

To assess if cell migration contributes to the invasive phenotype o f HNSCCs. we
examined cell motility o f HNSCCs by a chemotaxis assay. Similar to M atrigel invasion,
HNSCCs also exhibited different motilities. EVSCC14M and EVSCC17M were highly
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motile, whereas EVSCC18, EVSCC19M, UMSCC10A and FaDu were less motile
(Fig.3-2).
2000

M

1000

Fig.3-2 Cell migration of HNSCC lines. Migration assay were performed

as described for the chemoinvasion assay, except that polycarbonate
membranes were coated with diluted gelatin. The results are the means
(bars.SE) of two independent experiments.

b. MMP secretion.

Because MMPs play an important role in cancer cell invasion and MMP
expression is correlated with the metastatic capacity o f various tumors (reviewed in 19),
we screened HNSCC cell lines for MMP secretion by gelatin zymography. and
quantitated levels o f gelatinolytic activity by densitometry as described previously (78).
All HNSCC cell lines secreted MMP-2 and/or MMP-9 (Fig3-3). EVSCC19M and
UMSCC10A cells secreted increased MMP-9 relative to MMP-2, whereas EVSCC14M
and EVSCC18 cells secreted MMP-2 at higher levels than MMP-9; FaDu cells secreted
minimal levels o f both M MP-2 and MMP-9 (Fig.3-3 and Fig.3-4).
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MMP-9 92KD
MMP-2 72kO

F ig.3-3 MMP production by head and neck cancer cell lines. Cells were

incubated in serum free medium for 24 hrs and the conditioned medium (CM)
collected. The MMP activity in CM was assessed by gelatin zymography.
Shown is a representative zymogram of CM from HNSCC cell lines. Arrows
indicate the position of 92 kD MMP-9 and 72kD MMP-2.

Taken together with Matrigel invasion and cell migration, the results indicate an

30

□ MMP-2

o

8

a3

<

Fig.3-4 Quantitative densitometry of MMP production by HNSCC

cell lines. MMP activity of CM was assessed by gelatin zymography
and quantitated by densitometric scanning of individual lanes and
expressed as net intensity.
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association between MMP-2 secretion and invasion (See Summary o f HNSCC
Phenotypes Table 1. p.54).

The correlation was seen most dramatically with highly

invasive EVSCC14M and control A431 cell lines which secreted abundant amounts o f
MMP-2 but barely detectable MMP-9.

Conversely, weakly invasive EVSCC19M and

UMSCC10A cells secreted enhanced levels o f MMP-9 but reduced levels o f MMP-2
suggesting that a threshold level o f MMP-2 activity may be required for invasion in a 5
hour in vitro invasion assay. EVSCC18 cells were a notable exception to the association
between MMP-2 secretion and invasion. However, EVSCC18 cells exhibited limited
migration potential despite enhanced MMP-2 secretion (see Fig. 3-4) emphasizing the
interdependence o f MMP secretion and cell migration in the fully invasive phenotype.
Finally, the weakly invasive and migratory phenotype o f FaDu cells which secrete barely
detectable MMPs support the notion that MMPs play an important role in the invasive
potential o f HNSCCs.

To confirm the results o f MMP production detected by zymography. cell lysates
and conditioned media (CM) from the HNSCC lines were analyzed for MMP expression
by immunoblotting with MMP-specific antibodies. Since zymography demonstrated that
MMP-2 was associated with the invasive phenotype o f HNSCCs, we focused on MMP-2
expression in subsequent experiments. In preliminary experiments, we detected minimal
MMP-2 by immunobloting o f non-concentrated conditioned media from MMP-2 over
expressors, HT1080 and

EVSCC14M. Therefore, we used

10-fold concentrated

conditioned media for further analyses. We found that MMP levels in the conditioned
media detected by immunoblotting (Fig. 3-5, middle panel) correlated in part, but not
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exactly, with MMP activity as assessed by zymography (Fig.3-5, upper panel). For
example. EVSCC14M. EVSCC17M. EVSCC18, and A431 which exhibited the higher
levels o f MMP-2 activity by zymography, also showed elevated levels o f M M P-2
production detected by western blot analysis. Similarly, EVSCC19M. UM SCC10A and
FaDu. which had lower levels o f M MP-2 detected by zymography. consistently exhibited
reduced MMP-2 protein detected by immunoblotting. In western blot analysis, we also
detected lower molecular weight bands (see lane 1 and lane 2. Fig. 3-5) w hich may

92 kO. MMP-9 - •
72 kD, MMP-2 - *

Zymography

Western Blot
CM 10X

72 kD. MMP-2 —

Western Blot
cell lysates

72 kD, MMP-2 —

£

£
&

&

J?

£

,p° &
#

Fig. 3-5 MMP production by HNSCC cell lines: comparison of zymography
and immunoblotting. Each experiment has been repeated 2-3 times. Upper
panel shows a representative zymogram of CM from HNSCC cell lines.
The middle panel is a representative anti MMP-2 western blot of 10x CM
from HNSCC cell lines. The lower panel represents the anti-MMP-2 western
blot analysis of cell lysates (50 pg protein/lane) of HNSCC cell lines. Arrows
indicate the position of 92 kD MMP-9 and 72 kD MMP-2.

represent activated forms o f MMP-2.

We also analyzed MMP-2 expression in

cell

lysates o f HNSCC cells by western blotting. MMP-2 expression in cell lysates was
correlated generally with MMP-2 secretion in m ost cell lines except FaDu and A431.
FaDu exhibited a high level o f M M P-2 protein in cell lysates but
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enzyme activity in CM. In contrast, A431, exhibited minimal MMP-2 protein in ceil
lysates but showed high levels o f MMP-2 enzyme activity in CM

(compare Fig.3-5,

middle and lower panels). Data presented in Fig 3-5 shows minimal MMP-2 detected by
western blotting in CM o f HT1080 cells compared to a strong bound o f enzymatic
activity detected by gelatin zymography. In repeated experiments. MMP-2 levels detected
by western blot in CM o f HT1080 were comparable to levels detected by zymography.

b.

TIMP-2 secretion

We have characterized MMP secretion by HNSCC cell lines and demonstrated
that MMP-2 is associated with cells o f high invasive potential. Because TIMP-2 forms a
specific 1:1 complex with MMP-2 (62), we assessed TIMP-2 expression and secretion by
HNSCC cell lines.

To assess TIM P-2 secretion, concentrated conditioned media collected from
HNSCC cell lines, was subjected to reverse zymography using EVSCC18 conditioned
medium as the source o f MMP-2. Conditioned medium from HT-1080 fibrosarcoma
cells, known to secrete TIMP-1 and TIMP-2, was used as a positive control.

As expected, two undigested bands (the 27 kD, TIMP-1

and 21 kD, TIMP-2)

were detected in HT1080 conditioned media in original gel, but are barely visible in the
photographic reproduction o f the gel ( Fig. 3-6, upper panel, lane 1). CM from HNSCC
cell lines exhibited different levels o f TIMP-2 activity. EVSCC14M and EVSCC18
showed detectable levels o f TIMP-2 activity, whereas the other cell lines

R e p ro d u c e d with perm ission of the copyright owner. Further reproduction prohibited without permission.

showed

47

minimal to no TIMP-2 activity (Fig.3-6, upper panel). HNSCC cell lines also exhibited
different levels o f TIMP-1 activity detected as a 27 kD band by reverse zymography. In
addition to TIM P-l and TIMP-2, CM from EVSCC14M and EVSCC18 cells displayed a
third band with a molecular weight between TTMP-1 and TIMP-2.

Reverse
TIMP-2. 21 kD

TIMP-2, 21 kD 1

Western Blot
C.M 10X

TIMP-2. 21 kD*

Western Blot
cell lysates

<

<</*</

/r
<C

/ /

/ /

'

Fig. 3-6 TIMP-2 expression and secretion by HNSCC cell lines. TIMP-2

secretion in CM was analyzed by reverse zymography (upper panel) and
confirmed by immunoblotting (middle panel) as described in Materials and
methods). TIMp-2 expression in HNSCC cell lines was analyzed by immuno
blotting using cell lysates from HNSCC cell lines. Each is experiment has been
repaeted 2-3 times. Shown is a representative data from each experient.

To confirm TIMP-2 detection by reverse zymography, concentrated conditioned
media were analyzed by immunoblotting using a monoclonal antibody to TIMP-2. Levels
of TIMP-2 detected by immunoblotting correlated closely with levels detected by reverse
zymography (Fig.3-6. middle panel) with the exception o f HT1080 (lane l) in this
experiment as noted above.

We further assessed TIMP-2 protein expression in HNSCC cell lines by
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immunoblotting analysis o f cell lysates. TIMP-2 expression was correlated with TIMP-2
secretion in 4 out o f 6 cell lines. TIMP-2 detected in cell lysates o f FaDu and A431 was
not detected by immunoblotting or reverse zymography in CM (compare Fig.3-6. lower
panel with middle and upper panels).

d. Cellular adhesion o f HNSCC cells to ECM proteins.

Cell adhesion to the ECM. mediated by integrins, is a critical step in the process
o f invasion. To further characterize the invasive phenotype o f HNSCC cells, we assessed
the ability o f cells to adhere to ECM proteins by an in vitro cell adhesion assay as
described in the Materials and Methods section. In this assay, cell adhesion is measured
by the protein-binding dye, SRB. In a preliminary experiment, we demonstrated a linear
relationship between the number o f cells and optical density (490 nm) o f SRB staining
(Fig.3-7) with a regression coefficient o f 0.994 (p<0.001). The limit o f the SRB assay is
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Fig. 3-7 Relationship between number of cells and SRB staining. Cells were
plated at densities from 2500 to 5x104 cells per well in a 96 well tissue culture
plate, allowed to attach overnight and the SRB assay performed as described
in Materials and Methods. Shown is a regression analysis of the data. The
regression coefficient is 0.994. P<0.001.
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between 5000 and 5 xlO4 cells/well (Fig. 3-7). Therefore, the SRB assay was used in
subsequent experiments to enumerate the num ber o f adherent cells in adhesion assays.

To determine the optimal dose o f ECM proteins for adhesion assays, EVSCC14M
and EVSCC17M cells were tested for their ability to attach to 96 well plates coated
overnight with 0.1 pg - 100 pg/ml o f fibronectin. laminin. or type IV collagen. Plates
coated with 100 pg/ml o f

BSA were used as negative controls. EVSCC14M cell

adhesion was potentiated by laminin or fibronectin in a dose dependent manner, whereas
adhesion to type IV collagen was not dose-dependent (Fig. 3-8). Fibronectin or laminin
(100 pg/ml each) increased EVSCC14M cell attachment approximately 20-fold (Fig. 38). Likewise, laminin or fibronectin, but not type IV collagen, potentiated the dose-

BSA
1 ng/ml
10 ng/ml
100 tig/ml

Collagen IV

Laminin

Fibronectin

Fig. 3-8 EVSCC14M cell adhesion to ECM proteins. Cell adhesion assay
was performed as described in Materials and Methods. The results are the
means (bars, SE) of two independent experiments, with a total of six
replicates.Cell adhesion to ECM proteins was significantly increased as
compared to BSA (P<0.001).

dependent adhesion o f EVSCC17M cells (Fig.3-9). We noted that EVSCC17M cells
exhibited a higher background attachm ent to wells coated with BSA alone than
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EVSCC14M cells. Nevertheless, fibronectin or laminin (100 pg/ml each) increased
EVSCC17M cell attachment 5 fold and 3 fold, respectively (Fig. 3-9).

mmm

bsa

1 Mg/ml

■ ■ ■ 10 iig/ml

Laminin Fibronectin Collagen IV

Fig. 3-9 EVSCC17M cell adhesion to ECM proteins. Cell adhesion assay
was performed as described in Materials and Methods. The results are the
means (bars, SE) of two independent experiments, with a total of six
replicates.Cell adhesion to ECM proteins was significantly increased as
compared to BSA (P<0.001).

Since EVSCC14M and EVSCC17M cell attachment was highest at 100 pg/ml
ECM protein doses, we assessed the ability o f the other HNSCC cell lines to adhere to
plates coated with 100 pg/ml o f collagen type IV. fibronectin, laminin, or Matrigel (a
combination o f type IV collagen, laminin, and fibronectin). HNSCC cell lines adhered
poorly to BSA except EVSCC17M (data not shown). HNSCC cells exhibited a
differential ability to adhere to ECM proteins. EVSCC14M, 17M 19M, and UMSCC10A
were significantly more adhesive than weakly adhesive EVSCC18 and FaDu cells (Fig.
3-10). Cell ahesion to ECM proteins was correlated with Matrigel invasion in 4 o f the 6
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cell lines (See Table 1 Summary o f HNSCC Phenotypes, p.54). Interestingly, cell
adhesion to fibronectin was correlated with Matrigel invasion in 5 o f 6 cell lines.

Cell adhesion to ECM proteins such as type IV collagen, fibronectin, and laminin
is mediated by cell surface integrin receptors. Integrins bind ECM proteins by
recognizing specific peptide sequences (30). For example, fibronectin and other ECM

Fig. 3-10 HNSCC cell adhesion to ECM proteins. Cell adhesion assay
was performed as described in Materials and Methods. The results are the
means (bars, SE) of two independent experiments, with a total of six replicates.
EVSCC14M, 17M, 19M and UMSCC10A are more adhesive to ECM proteins
than EVSCC18 and FaDu. The difference between two groups was significant
(P<0.001).

proteins contain arginine-glycine-aspartic acid (RGD) sequences that serve as binding
sites for integrin receptors (30). To demonstrate the specificity and biological relevance
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o f cell adhesion to ECM proteins, cells were treated with a synthetic RGD peptide at
various concentrations to test for the capacity to competitively inhibit cell adhesion.
In initial experiments, we tested the efficiency o f a synthetic RGD tripeptide to inhibit
EVSCC17M cell adhesion to collagen type IV, fibronectin, or laminin (Fig. 3-11). A
RGE containing nucleoprotein (NP) peptide derived from influenza virus served as a

99

t

0.3

■b s a
■ECM, lOOug/ml
□NP
®0.5 mM, RGD
~l 1 mM, RGD
>2m M ,RG D
U m M ,R C D .

3
u
■c
c

ju
a.
O
Collagen IV

Fibronectin

Laminin

Fig. 3-11 Inhibition of EVSCC17M adhesion to ECM proteins by RGD
tripeptide. Cells were preincubated with RGD peptide 30 before the adhesion
assay. The adhesion assay was performed in 96 well tissue culture plates
coated with 100 ng/ml ECM proteins as described in Material and Methods
section. The data represents the mean (bar, SE) of two independent
experiments. Statistical analysis showed that the difference between the 4 mM
NP peptide and 4mM RGD tripeptide treatment was significant (p<0.05).

negative control. NP peptide (4mM) had no effect on EVSCC17M adhesion to ECM
proteins. RGD tripeptide inhibited EVSCC17M cell adhesion to fibronectin and laminin
in a dose dependent manner. However, the inhibition was not very potent and required
high concentrations o f RGD (4mM) (Fig.3-11). The RGD tripeptide had no effect on
EVSCC17M cell adhesion to Type IV collagen (Fig.3-11). Since cell adhesion to
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fibronectin is correlated with the invasive phenotype in most o f HNSCC cell lines, we
then tested the capacity o f a fibronectin-specific recognition RGD peptide (GRGDS) to
inhibit EVSCC17M cell adhesion to fibronectin. A RGE peptide (GRGES) was used as a
negative control. Peptide GRGDS inhibited EVSCC17M adhesion to fibronectin in a
dose-dependent manner, whereas the control RGE peptide had no effect (Fig.3-12).
GRGDSP peptides were more potent competitive inhibitors o f adhesion to fibronectin
than RGDESP tripeptides ( compare Fig.3-12 and Fig. 3-11).

_

BSA. 100 ng/ml
::t . z Fn. 10 pg/ml
Fn & RGD or RGE. 0 5mM
Fn & RGD or RGE. 1 mM
:------■ Fn & RGD or RGE. 2mM
■ ■ Fn & RGD or RGE. 4mM

illili

DRGESP GRGDSP
Fig. 3-12 Effect of peptides GRGDSP and GRGESPon EVSCC17M
adhesion to fibronectin. Cells were preincubated with peptide 30 minutes
before the adhesion assay. The adhesion assay was performed in 96 well
tissue culture plates coated withlOO pg/ml fibronectin (Fn) as decribed in
Material and Methods section. The data represents the mean (bar, SE) of
two independent experiments. Statistical analysis showed that difference
between RGD and RGE peptide treatment was significant (p<0.001).

In summary, we have characterized the invasive phenotype o f HNSCC cell lines
by

evaluating Matrigel invasion, cell migration, cell adhesion, and MMP/TIMP

production. (Table

1). HNSCC

cell lines showing high invasion and motility

(EVSCC14M, EVSCC17M) or weak invasion and reduced motility (EVSCC18,
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EVSCC19M. UMSCC10A. FaDu) were identified. In vitro adhesion assays showed a
differential adhesion o f HNSCC cells to ECM proteins and HNSCC cell adhesion to
fibronectin was RGD dependent. Gelatin zymography and western blot analysis

Table 1. Sum m ary of HNSCC Phenotypes

Cell line

Enhanced
Matrigel Enhanced
invasion migration

Enhanced
MMP-2

Enhanced Enhanced Enhanced
adhesion to Invasive
MMP-9
TIMP-2 ECM proteins potential

EVSCC14M

+

+

+

-

+

+

high

EVSCC17M

+

+

+

+

+ /-

+

high

EVSCC18
EVSCC19M

-

-

+

+

+

-

weak

-

-

-

+

-

+

weak

UMSCC10A

-

-

-

+

-

+

weak

+/-

+/-

-

-

-

-

weak

FaDu

Key findings: 1) Matrigel invasion and enhanced migration are closely linked.
2) Enhanced MMP-2 secretion, but not MMP-9, is associated with
invasive potential.
3) Cell adhesion to ECM proteins may be necessary but is not sufficient
for in vitro invasion.
4) TIMP-2 secretion is not associated with Matrigel invasion.

demonstrated a differential secretion o f 72kD and/or 92 kD type IV collagenase (MMP2 and/or MMP-9) by HNSCC cell lines. Matrigel invasion was associated with cell
adhesion to ECM proteins in 4 o f 6 cell lines and was correlated with MMP-2 secretion in
5 o f 6 cell lines. TIMP-2 secretion did not correlate with Matrigel invasion, suggesting
that alterations o f MMP-2 rather than TIMP-2 are important in generating the invasive
phenotype o f HNSCCs.

3-2 Determine the degree to which MMP production and migration may be regulated by
cell- ECM interactions
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a. Determine the role o f cell-ECM interaction in regulation o f MMP production by
HNSCC cell lines.

Cell adhesion to the ECM represents the initial step in the process o f tumor invasion.
Tumor cell-ECM interaction is hypothesized to stimulate MMP secretion and/or
activation resulting in proteolysis o f the basement membrane barrier and escape o f tumor

EVSCC14M

EVSCC17M

Fibronectin

Laminin

Fig. 3-13 Effects of ECM protein on MMP production by HNSCC cell lines.

Cells were treated with 10, 20, 40,or 80 ng/ml of fibronectin or laminin for
24 hours, and MMP activity in CM was assessed by gelatin zymography
as described in Materials and Methods. Shown is a representative zymogram
of CM from EVSCC17M, EVSCC14M and EVSCC18. The Mr 92,000 and
72,000 MMP activities are indicated (kD).

cells from the primary tumor site.

W e have shown previously that highly invasive

HNSCC cells constitutively produced MMP-2 at high levels (Section 3-lb).

However.

MMP-2 secretion may be required but not sufficient for acquisition o f the invasive
phenotype. We hypothesize that cell binding to ECM proteins promotes secretion and
activation o f latent MMP-2 thus facilitating degradation o f the basement membrane.
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Highly invasive (EVSCC14M . EVSCC17M) and weakly invasive EVSCC18 cells were
used to examine the effect o f cell adhesion to ECM proteins on MMP secretion and/or
activation. Cells were harvested, resuspended in serum-free growth medium with ITS.
plated in 24 well tissue culture plates and adherent cells treated with serum-free media
containing 10. 20. 40. or 80 pg/ml o f either type IV collagen, fibronectin or laminin for
24 hours. Cells treated with 80 pg/ml o f BSA for 24 hours were used as negative

■ BSA,80ugAnI
■ Fa 10 ug/mi
□ Fa 20 ug.ml
□ Fa 40 ug/ml
■ Fa 80 ugAnl

50 -i
45
40
35
25*
55 30 c
0) 25
c 20
15
z
10
5
0

■ Laminin. 10 ug/ml
■ Laminin. 20 ug/ml

□ Laminin. 40 ug/ml
■ Laminin. 80 ug/ml

EVSCC14M EVSCC17M

EVSCC18

Fig. 3-14 Quantitative densitometry of MMP-9 production following
treatment with fibronectin and laminin. Cells were treated with fibronectin
(Fn) and laminin at various concentrations for 24 hours, and MMP activity
was measured by gelatin zymography. MMP-9 activity was quantitated by
Kodak Digital Science 1D™ software program.

controls. CM was collected for gelatin zymography and analyzed for secretion o f latent
and activated

form s o f MMP-2/ MMP-9. The results are shown in Fig.3-13 and

displayed quantitatively in Fig. 3-14. BSA had no effect on MMP production (data not
shown). Fibronectin stimulated MMP-9 production by EVSCC14M and EVSCC17M in a
dose-dependent manner. However, MMP-9 secretion by EVSCC18 cell was only seen at
the higher doses o f fibronectin (Fig. 3-13 and Fig.3-14). Furthermore, higher doses o f o f
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fibronectin (40 ug/ml and 80 pg/ml) resulted in the secretion o f activated forms o f MMP9 visualized as a more rapidly migrating band o f 84 kD (Fig. 3-13). In contrast to the
stimulation o f MMP-9 secretion, fibronectin had minimal effects on MMP-2 secretion by
all cell lines assessed (Fig. 3-13 ). Laminin had no effect on MMP-2 production by any o f
the cell lines but did appear to weakly stimulate MMP-9 secretion by EVSCC17M (Fig.
3-14). Low doses o f collagen type IV had no effect on MMP production by HNSCC cell
lines (data not shown); however, higher doses o f type IV collagen (40 pg/ml) inhibited
MMP production. (Fig. 3-15).

EV SCC 14M E V SC C 18

EVSCC17M

MMP-9"^
MMP-2-*

E V SC C 14M

EVSCC18

EVSCC17M

Fig. 3-15 Effect of ECM proteins on MMP production by HNSCC cell lines. Cells
were treated with 40 pg/ml of ECM proteins for 24 hours, and MMP activity in CM
was assessed by gelatin zymography as described in section 2.2. The upper panel
is a representative zymogram. The lower panel is the quantitative densitometric
analysis of the zymogram by Kodak digital science program.

b. Regulation o f HNSCCs migration by cell-ECM interaction

Cell-ECM interactions not only modulate MMP production but also regulate cell
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Fig. 3-16 Effect of fibronectin on cell migration of HNSCC cell lines. The

migration assays were performed in modified Boyden chambers using various
concentrations of fibronectin as chemoattractant as descibed in section 2.
The results are mean (bar, SE) number of migrated cells per high power field
(400X) from two independent experiments. The difference between cells
treated with 10-40 pg/ml of fibronectin versus BSA treatment was significant
for EVSCC14M and EVSCC17M (P<0.001) but not for EVSCC18 (P>0.05).

migration. Several ECM glycoproteins, including vitronectin, fibronectin. laminin. and
type IV collagen have been found to stimulate locomotion in different types o f tumor

BSA. 1 0 0 u g/m l
L am inin . 1 u g /m l
L am inin . 10 u g/m l
L am inin . 20 u g /m l
L am inin . 4 0 t»g/ml
Lam in in. 80 (ig/ml

EVSCC14M

EVSCC17M EVSCC18

Fig. 3-17 Effect of laminin on cell migration of HNSCC cell lines. The migration
assays were performed in modified Boyden chambers using various concentrations
of laminin as chemoattractant as descibed insection 2. The results are mean
(bar, SE) number of migrated cells per highpower field (400X) from two independent
experiments. The difference between cells treated with 20-80 pg/ml laminin versus
he BSA treated group was significant for EVSCC14M and EVSCC17M cells (P<0.001)
but not for EVSCC18 (P>0.05).
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cells (14-17). To test the hypothesis that ECM proteins might regulate m igration of
HNSCC cells, we performed cell migration (chemotaxis) assays in the presence or
absence o f different concentrations o f soluble ECM proteins as chemoattractants. The
effects o f fibronectin, laminin, or collagen type IV on migration o f EVSCC14M.
EVSCC17M and EVSCC18 cells are shown in Fig. 3-16. 3-17, and 3-18 respectively .
Without any chemoattractant (BSA control), EVSCC14M and EVSCC17M cells were
highly motile, whereas EVSCC18 cells were poorly motile (P<0.0001). Fibronectin and

M M

B S A . 1 0 0 f i g /m l
C o l l a g e n IV. 1 u g / m l
C o l l a g e n IV. 10 u g / m l
M M C o l l a g e n IV. 2 0 u g / m l
i
i C o l l a g e n IV. 4 0 u g / m l

o

EVSCC14M EVSCC17M EVSCC18

Fig. 3 -1 8 Effect of collagen type IV on cell migration of HNSCC cell lines.
The migration assays were performed in modified Boyden chambers using
various concentrations of type IV collagen as chemoattractant as descibed in
section 2. The results are mean (bar, SE) number of migrated cells per high
power field (400X) from two independent experiments. The difference between
cells treated with 20 pg/ml collagen type IV versus the BSA control was
significant for EVSCC14M and EVSCC17M (P<0.001) but not for EVSCC18
fP>0.05T

laminin stimulated EVSCC14M and EVSCC17M cell migration dose- dependently
(P<0.0001).

whereas neither protein

stimulated

EVSCC18 chemotaxis,

intermediate doses o f fibronectin (1 pg/ml to 40pg/ml)

Low to

stimulated cell migration of

R e p ro d u c e d with perm ission of the copyright owner. Further reproduction prohibited without permission.

EVSCC17M and EVSCC14M cells, whereas a higher dose (80 fig/ml) was ineffective in
stimulating cell migration (Fig.3-16). This biphasic stimulation o f cell migration was not
observed with laminin (Fig.3-17). Collagen type IV also stimulated cell migration o f
EVSCC14M and EVSCC17M cells but not EVSCC18 (Fig.3-18). However, although cell
migration o f EVSCC14M by collagen type IV exhibited a dose-dependent effect,
stimulation o f EVSCC17M cell migration by collagen type IV was restricted to a dose o f
20 pg/ml.
■ ■ ■ i BSA. 10 0 u g /m l
— - Fn. 30 u g / m l
Fn & R G D o r R G E .
k s b Fn & R G D o r R G E .
Fn & R G D o r R G E .
Fn & R G D o r R G E .
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Fig.3-19 Effect of RGD or RGE peptide on EVSCC14M migration in response to
fibronectin. Migration assays were performed as described in section 2.1
using 30 pg/ml fibronectin (Fn) as chemoattractant Cells were pretreated with
RGD or RGE peptide at concentrations indicated in figure legend. The results
are mean (bar, SE) number of migrated cells per high power field from at least
two independent experiments. GRGDS inhibited cell migration dose-dependently.
The difference between RGD treatment and RGE treatment to inhibit Fn-stimulated
migration was statistically significant (P<0.001).

To determine the specificity o f cell adhesion to ECM proteins on cell migration.
EVSCC14M and EVSCC17M cells were pretreated with RGD peptide, GRGDS. which
is predicted to block cell surface integrin binding sites to fibronectin and thus inhibit the
signals that promote migration.

Pretreatment o f cells with the RGE peptide, GRGES,

R e p ro d u c e d with permission of the copyright owner. Further reproduction prohibited without perm ission.

served as a negative control. The migration assays were performed using 30 pg/ml of
fibronectin as the chemoattractant. Cell migration without chemoattractant was used as
baseline. As expected. EVSCC14M and EVSCC17M were highly motile in the absence
of chemoattractant (Fig. 3-19 and Fig.3-20). Treatment o f cells with 30 pg/ml of
fibronectin increased EVSCC14M and EVSCC17M

cell migration by 1.5-2 fold

(P<0.01). GRGDS peptide inhibited EVSCC14M and EVSCC17M cell migration dosedependentlv (P<0.001). whereas GRGES had no inhibitory effect (Fig 3-19 and Fig. 320 ).
BSA. 100 pQ/mt
,_z:_ Fn. 30 pg/m!
M M Fn & RGD o r RGE.
■ ■ i Fn & RGO o r RGE.
Fn A RGO or RGE.
^ ^ B Fn & RGD o r RGE.

GRGES

0 5mM
1fn M
2mM
4mM

GRGDS

Fig.3-20 Effect of RGD or RGE peptide on EVSCC17M migration in response
to fibronectin. Migration assays were performed as described in section 2.1
using 30 ug/ml fibronectin (Fn) as chemoattractant. Cells were pretreated with
RGD or RGE peptide at concentrations indicated in figure legend. The results
are mean (bar, SE) number of migrated cells per high power filed (400X) from
at least two independent experiments. GRGDS inhibited cell migration
dose-dependently. The difference between RGD treatment and RGE treatment
to inhibit Fn-stimulated migration was statistically significant (P<0.001).

3-3. Determine the role o f MMPs in invasion o f HNSCC

Proteolytic degradation o f the ECM is an important step in tumor invasion. The
data presented in section 3.1 showed that MMP-2 production was associated with
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Matrigel invasion by EVSCC14M cells. Because increased expression o f MMPs by

malignant tumor cells is believed to play an essential role in invasion, we hypothesized
that MMP-2 production was necessary for the invasion o f HNSCC cells. To test this
hypothesis, we assessed the effect o f antibody specific for M MP-2 on the invasive
potential o f EVSCC14M cells. We reasoned that if MMP-2 production was necessary
for. and not simply correlated with, the invasive potential o f head and neck tumor cells.
then neutralization o f MMP-2 activity should block in vitro invasion o f EVSCC14M
cells.

EVSCC14M Cells were treated with polyclonal antibody to M MP-2 or normal rabbit
serum and assessed for Matrigel invasion. Normal rabbit serum had no effect on Matrigel
invasion by EVSCC14M. Neutralizing antibody to MMP-2 inhibited EVSCC14M cell
invasion dose-dependently. The maximum inhibition was greater than 50% (P<0.001) at
a dose o f lOOjig/ml (Fig.3-21).
x
o

o'T

Dosage of anti MMP-2 antibody
Fig. 3-21 Dose dependent inhibition of Matrigel invasion of EVSCC14M by antibody
to MMP-2. Invasion assays were conducted with Matrigel coated 8 um-pore size
polycarbonate membranes in a modified Boyden chamber. Various concentrations
of anti-MMP-2 antibody were added to the upper chamber and invasion was
measured after 5 hours exposure to 3T3 CM. The results are mean number (bar,
SE) of invaded cells per high power field (HPF) with 400X magnification. Antibody
significantly inhibited matrigel invasion by EVSCC14M (P<0.001).
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3-4. Calcium-dependent signaling and the invasive phenotype o f HNSCCs

Accumulating

data

have

demonstrated

that

integrin-mediated

cell-ECM

interactions are important in the regulation o f a variety o f cell functions including cell
migration and MMP production (49,82). A comm on regulatory point in several integrin
signaling pathways is intracellular calcium homeostasis. Calcium represents a signaling
molecule essential in many signal transduction pathways and is known to regulate a
number o f biochemical processes, including cell proliferation, invasion, angiogenesis.
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Fig. 3 -2 2 Effect of CAI on agonist-induced elevation o f[C a 2*] in

EVSCC17M and FaDu cells. EVSC C 17M and FaDu cells were
loaded with Fura-2 and preincubated with 20 uM CAI for 30 min
before agonist [ EGF(200ng/m l) and bradykinin (1 (o.M ) ] addition,
indicated by arrow. Untreated cells were incubated with an
equivalent amount of DMSO vehicle.

and secretion (125).

To investigate if calcium-dependent signaling pathways were

important in the biology o f HNSCC. we made use o f a novel inhibitor o f calcium influx.
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carboxyamido-triazole

(CAI).

transduction events (126).

that

selectively

blocks

calcium-mediated

signal

Previous reports have shown that CAI inhibited the

proliferation and invasive behavior o f malignant cells in vitro and in animal tumor
models (119.121.127). However, the effect of CAI on the proliferation and invasiveness
o f head and neck tumor cells was not known. We first evaluated the effect o f CAI on
calcium influx in EVSCC17M and FaDu cells treated with two general calcium agonists,
epidermal growth factor (EGF) and bradykinin. Using cells loaded with the calcium
fluoroprobe Fura-2, we observed a rapid elevation of intracellular calcium levels in
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CAI Dosage (pM)
Fig. 3-23 D ose-dependent effect o f CAI on M atrigel invasion by
EV SC C 14M . C ells w ere treated with different dosages o f C A I and
M atrigel invasion w as perform ed as described in “ M aterials and
M ethods” . T he results are the m ean (bar, SE) o f tw o independent
experim ents w ith six replicas. The difference between CAI treated and
untreated group w as statistically significant (P<0.001).

EVSCC17M and FaDu cells treated with EGF and bradykinin, respectively (Fig.3-22).
The EGF effect on calcium in EVSCC17M cells was dose-dependent and was attenuated
>70% by EGTA in the assay buffer, indicating a significant calcium influx component
involved with calcium mobilization by EGF in HNSCC cells (data not shown).

R e p ro d u c e d with permission of the copyright owner. Further reproduction prohibited without perm ission.

65

Preincubation with 20 pM CAI markedly attenuated calcium elevation in both cell lines
(Fig. 3-22 A and B). Similar results were obtained with other agonists (data not shown),
confirming that CAI blocks agonist-induced calcium influx in HNSCC cells. We also
examined the dose dependency o f CAI to attenuate bradykinin induced elevations o f
intracellular free calcium. CAI at a concentration o f 1 pM produced a 10% inhibition,
whereas 10 pM CAI produced a maximum 50% inhibition ( data not shown). Increasing
the concentration o f CAI to 20 pM and 50 pM did not produce any further inhibition.
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F ig.3-24 Effect o f C A I on invasive potential o f H N SCC cell lines. Invasion assays were
conducted w ith M atrigel-coated 8 um pore size polycarbonate m em branes in a m odified
B oyden cham ber. C ells were exposed to m edium w ithout or with 10 uM C A I for 18 hours
p rio r to and during the assay. Invasion w as m easured after 5 hr exposure to 3T3 conditioned
m edium. Cells on the underside o f the m em brane w ere stained and counted by an image
analyzer. Results are the m ean + /- SE o f 2 independent experim ents with total o f 6
replicates. Inset: expanded scale o f H N SC C cells with w eak invasive potential. M ixed m odel
o f Nested A N O V A w as perform ed w ith assistance o f Instat2 softw are. D ifferences between
the high and low invasive cell lines are significant (p<0.05). Treatm ent o f C A I significantly
reduced the invasive potential o f all cell lines (P< 0.05) except EV SCC19M .
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We then tested the effects o f CAI on Matrigel invasion, cell migration, and MMP
production by HNSCC cell lines.

In preliminary experiments, we determined that the

effects o f CAI on parameters o f invasion were dose-dependent with half-maximal
inhibitory concentrations (IC50s) between 3 and 10 uM (Fig.3-23) and used 10 uM CAI
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Fig.3 -2 5 Effect of CAI on migration of HNSCC cell lines. Migration assays were

performed as described for the chemoinvasive assay, except that polycarbonate
membranes were coated with gelatin. The results are the means (bars, SE) of two
independent experiments. Inset, expanded scale of HNSCC cells with reduced
motility. Statistical analysis demonstrated that CAI significantly inhibited cell
migration of cell lines (P<0.05).

in subsequent experiments. Treatment o f HNSCC cells with CAI for 24 hours blocked
Matrigel invasion and cell migration 2-14 fold (Fig. 3-24 & 3-25) and inhibited MMP-2
production 3-7 fold (Fig. 3-26 & 3-27) relative to untreated control cells. CAI inhibited
in subsequent experiments. Treatment o f HNSCC cells with CAI for 24 hours blocked
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Matrigel invasion and cell migration 2-14 fold (Fig. 3-24 & 3-25) and inhibited MMP-2
production 3-7 fold (Fig. 3-26 & 3-27) relative to untreated control cells. CAI inhibited

MMP-2 72 kD

Fig.3-26 Effect of CAI on MMP production by HNSCC cells. Cells were treated without(-)
or with (+) 10 pM CAI for 24 h, and MMP activity in CM was assessed by gelatin
zymography. Shown is a representative zymogram of CM from EVSCC19M,EVSCC14M
and EVSCC18. CM from HT1080 was used as a positive control for MMP-9 and MMP-2
activity. The Mr 92,000 and 72,000 MMP activities are indicated (kD).
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Fig. 3-27 Quantitative densitometry of MMP production by HNSCC ceil

lines. Cells were treated without or with 10uM CAI for 24 hr and MMP
activity of conditioned medium assessed by gelatin zymography as
described in “ Materials and Methods”. MMP activity was quantitated by
densitometnc scanning of individual lanes and expressed as net intensity.
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MMP-9

secretion

less

effectively

(~1.5-fold

reduction).

Collectively,

the

data

demonstrate that calcium signaling is an important determinant o f the invasive
phenotype.

3-5 The role o f focal adhesion kinase in the regulation o f MMP production and
expression o f the invasive phenotype o f HNSCCs

We have demonstrated that inhibition o f calcium influx inhibited the invasive
potential o f HNSCCs in vitro (78). Work o f others has shown that inhibition of calcium
influx blocked FAK phosphorylation and kinase activity (89). Since activation o f FAK
has been functionally linked to the focal adhesion site and generation o f signals for
motility and invasion (80). we assessed the role o f FAK in regulation o f MMP production
and expression o f the invasive phenotype o f HNSCCs. To achieve this goal, we first
assessed expression and phosphorylation of FAK in HNSCC cell lines and then further
dissected the role o f FAK in generation o f the invasive phenotype by transfection studies.

a.

Expression and phosphorylation o f FAK and invasiveness o f HNSCCs

To assess FAK expression and phosphorylation, lysates from three moderately to
highly invasive HNSCC lines (EVSCC14M, EVSCC17M, A431) and two weakly
invasive cell lines (EVSCC18. FaDu) were immunoprecipitated with anti-FAK antibody.
Since FAK is a natural substrate o f src tyrosine kinase, lysates from R ati transfectants
overexpressing src (R ati src cells) served as a positive control. FAK immunoprecipitates
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were blotted with anti FAK antibody to assess FAK protein levels or antiphosphotyrosine
antibody (RC20) to assess FAK phosphorylation. Rati Src cells constitutively expressed
low levels o f FAK. which was highly phosphorylated (Fig.3-28).

IP FAK
Blot FAK

IP FAK
Blot RC20

Fig.3-28 Immunodetection of p125FAK and phosphorylation of p125FAK in

HNSCC cell lines. Cell lysates (800 pg protein) from near confluent HNSCC
and control cell lines were immunoprecipitated (IP) with anti-FAK antibody
and western blots probed with anti-FAK antibody or anti-phosphotyrosine
antibody RC20). Shown is an example of an immunoblot demonstrating
expression of p125FAK (upper panel) and the basal level of activated FAK
(lower panel) in HNSCC cell lines. R1-Src are rati ceils transformed by v-src.

Basal levels o f FAK expression varied ~3-fold between the cell lines (Fig. 3-28) with no
apparent correlation with the invasive phenotype. Interestingly, levels o f phosphorylated
FAK were correlated with invasion and cell migration. By densitom etric scanning, the
moderately to highly invasive cell lines (EVSCC14M , EVSCC17M, A431) exhibited 2 to
4-fold more phosphorylated FAK than the weakly invasive EVSCC18 or FaDu cells (Fig.
3-29). The findings support a role for FAK activation in regulation o f cell migration and
invasion.
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Fig. 3-29 Quantitative densitometry of FAK expression and basal levels of

phosphorylation of FAK in HNSCC cell lines.

b. Role o f FAK in expression o f the invasive phenotype o f HNSCCs by modulation o f
FAK expression and phosphorylation

We demonstrated that levels o f phosphorylated FAK were correlated with cell
migration and Matrigel invasion suggesting that FAK signaling may be involved in
expression o f the invasive phenotype o f HNSCCs. To further dissect the role o f FAK
signaling in generating the invasive phenotype o f HNSCC, sense or antisense FAK
cDNA as well as the carboxy-terminal isoform, FAK-related non-kinase (FRNK) were
expressed by stable transfection o f selected HNSCC cell lines. Modulation o f FAK or
FRNK expression was confirmed by immunoblotting and transfectants assessed for
invasive potential.
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I . Generation o f FAK and FRNK expression plasmids

FAK and FRNK cDNA from Bluescript phagemids were cloned in pSV.Sport 1 in
both the sense and antisense orientation. Sense and antisense FAK expression vectors
were verified by restriction digestion with Dral. As predicted, restriction analysis o f sense

1 2 3 4 5 6
Fig. 3-30 Restriction analysis of sense and antisense FAK expression
vectors. Sense and antisense expression vectors were digested with Ora
I. pSK.FAK and pSV. Sportl were used as controls. Lanel is 1 Kb DNA
marker Lane 2 is pSK.FAK, Lane 3 and Lane 6 is pSV. FAK. Lane 4 is
the antisense FAK expression vector pSV aFAK. Lane 5 is pSV Sportl.

FAK expression vector with Dra I generated 2899, 1430, 1420, and 692 bp fragments,
whereas restriction digestion o f the antisense FAK with the same enzyme resulted in
2634. 962. and 247 bp fragments (Fig. 3-30). Sense and antisense FRNK expression
plasmids were verified by restriction digestion with Hind III. Restriction digestion o f
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sense FRNK with Hind III generated 3.98 kb and 280 bp fragments, whereas restriction
digestion o f antisense FRNK resulted in 3.3 kb and 904 bp fragments (Fig.3-31).

___

I

1 2

3 4

5

Fig. 3-31 Restriction analysis of sense and antisense FRNK constructs.

pSV. FRNK and pSV.a FRNK were digested with Hind III. PSK.FRNK
was used as control. Lanel is 1 Kb DNA molecular marker. Lane 2 and
Lane 4 is pSK. FRNK cDNA. Lane 3 is the antisense FRNK expression
vector. Lane 5 is sense FRNK expression vector.

II.

Transfection, selection

and verification o f FAK or FRNK expression

and

phosphorylation by immunoblolting and immunoprecipitation

Weakly invasive cell lines with low levels o f FAK expression (EVSCC18) or
highly invasive lines with elevated levels o f FAK expression (EVSCC14M, EVSCC17M)
were used for DNA transfection (Table 2). Because polybrene had been used successfully
in our laboratory to introduce the EMS1 gene into 3T3 cells, initial experiments
concentrated on cotransfection o f sense FRNK with pSV2.neo into EVSCC14M cells
with polybrene. After three attempts with this method using various ratios o f pSV2.neo

R e p ro d u c e d with perm ission of the copyright owner. Further reproduction prohibited without permission.

73

Table 2: Invasive and FAK phenoype of cell lines used for transfection
EVSCC14M

EVSCC17M

EVSCC18

Matrigel invasion

High

High

Weak

Enhanced motility

+

+

-

Elevated FAK level

+

+

-

Enhanced FAK
phosphorylation

+

+

-

to pSV.FRNK. 38 colonies were obtained following G418 selection and clonal
expansion. None o f the G418 resistant clones overexpressed FRNK protein assessed in
cell extracts by w estern blot analysis with FAK antibody BC3, a polyclonal antibody
recognizing a carboxyl terminal FAK epitope (Table 3). Because the transfection
efficiency by polybrene was low (<1%) for HNSCC cells, we evaluated a number o f
different methods and reagents in an effort to achieve optimal transfection efficiency.
Techniques assessed for transfection efficiency included polybrene, calcium phosphate
precipitation, liposome-mediated transfection ( Tfx™, Promega, Madison, WI), Superfect
(Qiagen. Valencia. CA), and FuGene 6 (Boehringer Mannheim, Indianapolis, IN). Using
these transfection reagents and protocols provided by each manufacturer, we transfected a
P~gal plasmid or pSV2.neo plasmid into HNSCC cell lines to assess transient and stable
transfection efficiency, respectively. By this comparative analysis, we found that FuGene
6 reagent gave the highest transfection efficiency for most cells tested (data not shown).
Therefore, we used the FuGene 6 reagent for subsequent DNA
Cotransfection o f sense

transfections.

FRNK with pSV2.neo into EVSCC14M or EVSCC17M cells
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resulted in

18 and 13 stable transfectants, respectively. Immunoblotting analysis

identified 3 o f 18 EVSCC14M transfectants that overexpressed FRNK protein (Table3;

Table 3: Summary o f transfection experiments
Cell lines
expressor

Ratio o f
Gene/neo

FRNK/neo
(10-30:1)
FRNK/neo
(10:1)
aFA K 2/neo
(10:1)
EVSCC17M FRNK/neo
(20:1)
aFA K 2/neo
(20:1)
EVSCC18
FAK/neo
(20:1)
*
2

Transfection
Reagent

No. o f N eoR
Colonies

Positive
Clones *

Polybrene/
DMSO
FuGene 6

38

0

18

3

FuGene 6

8

2

FuGene 6

13

6

FuGene 6

18

2

FuGene 6

11

5

Assessed by immunoblotting with FAK antibody BC3.
aFA K : antisense FAK

Fig. 3-32) and 6 o f 13 EVSCC17M transfectants that overexpressed FRNK (Table 3).
Sense FAK and pSV2.neo cotransfection

o f EVSCC18 cells generated 11

stable

transfectants. of which 5 over-expressed FAK protein assessed by immunoblotting with
FAK antibody (Table 3, Fig. 3-39). A similar approach was used to introduce antisense
FAK into EVSCC14M and/or EVSCC17M, two HNSCC cell lines that exhibit high
levels o f FAK expression and phosphorylation and are highly invasive (Table 2). Two
clones in each group were identified that expressed decreased levels o f FAK (30% to
50% reduction as compared to neo control (Table 3). EVSCC14M (antisense FAK)
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and EVSCC17M (antisense FAK) transfectants were not studied further.

III. Assess the invasive phenotype o f FAK and FRNK transfectants.

1. Invasive phenotype o f FRNK transfectants

Data presented in section 3.5a demonstrated that FAK phosphorylation was
associated with the invasive phenotype o f HNSCC cell lines, suggesting that FAK
activation may contribute to the invasive potential o f HNSCCs. To further investigate the
role o f FAK activation in regulation o f tumor invasion, we overexpressed FRNK in

p125FAK

P41/43FRNK

Fig.3-32 Overexpression of FRNK in EVSCC14M cells by transfection.

FRNK expression plasmids were transfected into EVSCC14M as
described in the Materials and Methods section. pSV.neo alone was
transfected into EVSCC14M cells as a negative control. NIH3T3 cells
transiently transfected with FRNK served as a positive control. Cell
lysates were analyzed by immunoblotting with FAK antibody BC3 for FAK
and FRNK expression. 125 kD FAK and 41/43 kD FRNK are indicated.

EVSCC14M by transfection in an effort to inhibit FAK phosphorylation. Western blot
analysis showed that three FRNK clones (FRNK1, FRNK2, FRNK11) overexpressed
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FRNK by 5-7 fold as compared to neo control clones, whereas FAK level was not altered
by FRNK transfection (Fig.3- 32).

To assess the effect o f FRNK expression on FAK phosphorylation in EVSCC14M
FRNK transfectants. lysates from two clones pSV.FRNKl and pSV.FRNK2 were
immunoprecipitated with BC3 antibody and probed with BC3 for FAK and FRNK

protein expression, and RC20 antibody for FAK phosphorylation. EVSCC14M pSV.neol
and pSVneo2 clones served as controls. As expected, FRNK levels were 3-4 times higher

I.P FAK
Blot FAK
I.P FAK
Blot RC20
FRNK
Level

/ ^ ^ A
/
*/ / *
Fig. 3-33 Effect of FRNK expression on FAK phosphorylation in EVSCC14M

FRNK transfectants and controls. Cell lysates from FRNK or neo control clones
were immunoprecipitated with BC3 antibody. The immunocomplexes were
probed with BC3 for FAK and FRNK expression and probed with RC20
antiphosphotyrosine antibody for FAK phosphorylation.

in pSV.FRNKl and FRNK2 transfectants as compared to neol and neo2 controls (Fig. 333. lower panel). Expression o f FRNK slightly reduced FAK expression but inhibited
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Fig. 3-34. Photomicrography of Matrigel invasion by EVSCC14M FRNK
transfectants and controls. Chemoinvasion assays were performed in
modified Boyden chambers as described in section2.1. Photograph was
taken under 400 X magnification. A. pSV2.neo1 14M. B. pSV2.neo2.14M
C. pSV.FRNKl. 14M. D. pSV.FRNK2.14M

FAK phosphorylation greater than two fold (Fig3-33. middle panel). To characterize the

Fig.3-35 Matrigel invasion by EVSCC14M FRNK transfectants and controls. Invasion
assays were conducted with Matrigel-coated 8 nM- pore size polycarbonate membranes
in a modified Boyden chamber and was measured after 5 hours of exposure to 3T3
conditioned medium.Cells on the underside of the membrane were stained and counted
manually with 400X magnification. Data are represented as the number of invaded cells
per high power field (HPF). Results are means (Bars, SE) of two independent
experiments, with a total of six replicates. Statistical analysis showed a significant
difference in invasion between neo controls and FRNK transfectants (P<0.05).
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invasive phenotype o f EVSCC14M FRNK transfectants, Matrigel invasion assays were
performed using 3T3 CM as chemoattractant. Unexpectedly, FRNK overexpression
increased the invasive potential o f EVSCC14M approximately 50% as compared to neo
controls (p<0.05) (Fig. 3-34 and Fig.3-35) but did not change overall cell morphology.
Since MMP production is an important step in tumor invasion, we assessed MMP
production by EVSCC14M FRNK transfectants by gelatin zymography. FRNK
overexpression had very little effect on MMP-2 secretion, but promoted MMP-9
production by 20-40% (Fig.3-36).

92kO, MMP-9
72 kD, MMP-2

Fig. 3-36 MMP production by EVSCC14M FRNK transfectants and controls.
Cells were incubated with serum-free ITS medium for 24 hours, CM were
collected and MMP activity in CM was assessed by gelatin zymography as
described in section 2.2. The upper panel is a representative zymogram. The
lower panel is the quantitative densitometric analysis of the zymogram
by Kodak digital science 1D software program.

To

further

investigate

the

invasive

phenotype

of

EVSCC14M

FRNK

transfectants, we assessed the motility o f the transfectants by the chemotaxis assay using
3T3 CM or fibronectin as chemoattractants. FRNK transfectants were more motile than
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Fig. 3-37. Photomicrography of cell migration by EVSCC14M FRNK
transfectants. Cell migration assays were performed in modified Boyden
chambers with 30 fig/ml Fn as chemoattractant as described in section 2.1.
Photograph was taken under 200 X magnification. A. pSV2.neo1 14M. B.
pSV2.neo2.14M. C. pSV.FRNKl.14M. D. pSV.FRNK2.14M.

neo controls without chemoattractant. Similar to the parental cell line and neo control,
migration o f FRNK transfectants was stimulated by fibronectin dose dependently. In

Fig.3-38 Cell migration of EVSCC14M FRNK transfectants. Migration assays were
performed as described for the chemoinvasive assay, except that the polycarbonate
membranes were coated with gelatin. Both 3T3 CM and fibronectin (Fn) were used as
chemoattractants. Data are presented as the number of migrated cells per high power
(HPF 400X). The results are the means (bars, SE) of two independent
experiments.Statistical analysis demonstrated that FRNK significantly enhanced cell
migration as compared to neo controls (P<0.05).
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response to the same dose o f fibronectin or 3T3 CM , FRNK transfectants were more
migrative than neo controls CM (P<0.05) (Fig.3-37 and Fig.3-38).

2. Invasive phenotype o f EV SCC18 FAK transfectants

To assess directly the effect o f FAK overexpresion on the invasive phenotype o f
HNSCC. we transfected FAK into the low FAK expressor and weakly invasive cell line.
EVSCC 18. FAK overexpression in EVSCC 18 FAK transfectants was verified by
western blot analysis using antibody to FAK. The blot was reprobed with antibody to

Actin

Fig.3-39 Overexpression of FAK in EVSCC18 cells by transfection.

Sense FAK and pSV2neo or pSV2.neo alone were transfected into
EVSCC18 cells as described in Material and Methods. G418 resistant
clones were expanded and cell lysates analyzed by western blotting with
FAK antibody for FAK expression and reprobed with actin as an internal
control for loading.

actin as an internal control for equal loading. Figure 3-39 illustrates FAK overexpression
(2-4 fold) in EVSCC 18 FAK transfectants relative to the neo transfectant controls (Fig.339). EVSCC 18 FAK expression clones, pSV.FAK.4/18 and pSV.FAK.6/18 were selected
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as candidates for characterization o f the invasive phenotype assessed by Matrigel
invasion, cell migration, and MMP secretion. Two neo clones, pSV.neol/18 and
pSV.neo2/18 served as negative controls. In the absence o f chemoattractants (BSA alone)
EVSCC 18 FAK transfectants and neo controls were poorly invasive, similar to parental
EVSCC 18 cells (Fig. 3-41). In the presence o f CM as the source o f chemoattractants.
EVSCC 18 FAK transfectant clones exhibited substantially greater Matrigel invasion
relative to the neo controls ( Fig 3-40 and Fig. 3-41). This difference in Matrigel invasion

Fig. 3-40 Photomicrography of Matrigel invasion by EVSCC18

FAK transfectants. Matrigel invasion assays were performed with 3T3
CM as chemoattractant as described in section2.1. Photograph was
taken under 200 X magnification. A. pSV2.neo1/18. B. pSV2.neo2/18.
C. pSV.FAK4/18. D. pSV.FAK6/18.

between the FAK transfectants and neo controls was most pronounced in the presence of
fibronectin, which stimulated invasion in a dose-dependent manner (Fig. 3-41). Although
enforced FAK expression significantly increased the invasive potential o f EVSCC 18
cells, the extent o f Matrigel invasivion never reached the level o f highly invasive
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EVSCC 14M and EVSCC 17M cells (compare Fig3-41 with Fig 3-1). In addition, unlike
EVSCC14M and EVSCC17M cells, we observed that EVSCC18 FAK transfectants
appeared to clump together (Fig.3-40).

Fig. 3-41 Matrigel invasion by EVSCC18 FAK transfectants. Invasion assays were
conducted with Matrigel-coated 8 nM- pore size polycarbonate membranes in a modified
Boyden chamber and were measured after 5 hours of exposure to either 3T3 CM, BSA
or fibronectin at 15 pg/ml or 30ug/ml. Cells on the underside of the membrane were
stained and counted manually with 200X magnification. Data are represented as no.
of invaded cells per well. Results are means (Bars, SE) of two independent experiments,
with a total of six replicates. Statistical analysis showed that the difference between neo
and FRNK transfectants was significant (P<0.01).

To study the contribution o f MMP2/MMP-9 to the increased invasive phenotype
o f FAK transfectants, we assessed MMP-2/MMP-9 secretion in CM from EVSCC 18
transfectants and neo controls by gelatin zymography. Both FAK transfectants and neo
controls exhibited variable amounts o f MMP-2 secretion. O f interest, the more invasive
pSV.FAK4/18 clone secreted 2-fold more MMP-2 that the less invasive pSV.FAK6/18
clone or neo controls ( Fig. 3-42). MMP-9 secretion was increased by 3-4 fold in the
CM o f the two FAK transfectants compared to the extent o f M M P-9 secretion in neo
control clone (pSV neol) with the higher level o f secretion (Fig.3-42). Cell motility o f

R e p ro d u c e d with perm ission of the copyright owner. Further reproduction prohibited without permission.

83

EVSCC 18 FAK transfectants was assessed by chemotaxis using CM or fibronectin as
chemoattractants. Cell motility o f either EVSCC 18 FAK transfectants or neo controls
was low without chem oattractants (BSA alone).

92kD, MMP-9
72 kD, MMP-2

Fig. 3 -42 MMP production by FAK transfectants. Cells were incubated in serumfree ITS medium for 24 hours. CM collected and MMP activity assessed by gelatin
zymography as described in section 2.2. The upper panel is a representative
zymogram of two experiments. The lower panel is the quantitative densitometric
analysis of the zymogram by Kodak digital science 1D software program.
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Fig. 3-43 Cell migration of EVSCC18 FAK transfectants. Migration assays were
performed as described in Materials and Methods. Either 3T3 CM or fibronectin were
used as chemoattractants. Data are presented as number of migrated cells per well.
The results are the means (bars, SE) of two independent experiments.Statistical
analysis demonstrated that FAK overexpression significantly enhanced cell migration
in response to CM or fibronectin as compared with neo controls (P<0.01).
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Conditioned medium or increasing doses o f fibronectin stimulated motility o f EVSCC 18
neo controls to a limited extent, whereas CM or fibronectin potently stimulated motility
o f both EVSCC 18 FAK clones (Fig.3-43).

The pSV.FAK 6/18 clone, in particular,

exhibited a robust increase in cell motility when stimulated with CM or increasing doses
o f fibronectin (Fig. 3-43).
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CHAPTER IV
DISCUSSION

In the present study, we sought to identify and characterize determinants of
invasion by head and neck tumor cells. Utilizing a panel o f HNSCC cell lines previously
established in our lab, we tested the application and relevance o f the three-step
hypothesis o f tumor invasion to HNSCC and investigated the mechanism(s) pertaining to
the regulation o f each step in the invasive process. The results demonstrated that 1) tumor
cell invasion by HNSCC is a complex process involving three repeated sequential steps:
cell adhesion, proteolytic degradation o f the basement membrane, and migration;

2)

MMP-2 production is essential for Matrigel invasion by HNSCCs; 3) MMP production
and cell migration are regulated by integrin mediated cell-ECM interaction; and 4)
Regulation o f MMP production and cell migration by cell-ECM interaction depends on
calcium signaling and FAK activation.

4.1 Involvement o f three sequential steps: Cell adhesion, proteolytic degradation, and cell
migration in tumor invasion by head and neck tumor cells

Tumor invasion o f basement membranes is a crucial step for malignant
dissemination and marks the beginning o f metastasis by HNSCCs. Therefore, the ability
o f the tumor cell to breach the basement membrane defines the invasive phenotype o f a
tumor (13). Experimental measurement o f invasive potential is a challenging task.
Previously, a variety o f in vitro systems have been developed to assess the invasiveness
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o f tum or ceils (128). Several o f these assays utilized tissues containing basement
membranes, such as the bladder wall (129), amnion (130), lens capsule (131) and chick
chorioallantoic membranes (132).

Disadvantages o f these approaches included the

requirement o f fresh sample, uneven thickness o f the membrane, and the presence o f
microtears in the membrane that reduced the reproducibility o f the assay (133).
Subsequent studies have used pressed disks composed o f lyophilized collagen type IV
and laminin to test the invasiveness o f tum or cells in Boyden chambers (134). However,
disks were fragile after reconstitution and difficult to handle. To improve the handling
property, a porous membrane filter coated with Matrigel, a reconstituted mixture o f
basement membrane proteins, was used to assess tumor invasion in different systems
(133. 135). However, the original M atrigel assays required a long incubation time (72
hours), which is complicated by the need to account for cell division and also increased
the opportunity for bacterial contamination.

In the present study, we used Matrigel-

coated porous membrane filters in a m odified Boyden chamber to test the invasive o f
HNSCC cells in a 5 hour assay. NIH 3T3 cell conditioned medium, which contains
fibronectin.

collagen

(136),

scatter

factor

(123),

and

other

uncharacterized

chemoattractants was placed in the lower w ell beneath the filter to stimulate chemotaxis.
The 5 hour assay obviates the concerns o f cell division and microbial contamination that
hampered the longer assays.

Six head and neck cancer cell lines were evaluated for

invasive potential by this method.

The results demonstrated that HNSCC cell lines

spanned the spectrum from highly invasive EVSCC 14M and EVSCC 17M cells to weakly
or poorly invasive EVSCC 18, EVSCC 19M, FaDu, and UMSCC10A cells.

This

continuum o f invasive potential in vitro recapitulates the biologic phenotype o f HNSCC
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in vivo and emphasizes the value o f cell lines as representative o f the tum or o f origin. It
is important to point out that HNSCC cell lines are remarkably stable in vitro, both
cytogenetically and genetically, thus validating their use as experimental research models
(137).

Active cell locom otion is an important step in tum or invasion. To further
characterize the invasive phenotype, we assessed HNSCC cell lines for cell motility by a
chemotaxis assay. The results showed that highly invasive cell lines (EVSCC14M and
EVSCC17M) were also highly migratory whereas weakly invasive cell lines (EVSCC18.
EVSCC19M, FaDu, and UM SCC10A) were less motile. Our results are consistent with
previous reports o f other tum or cell types (138,139). The close relationship between cell
motility and Matrigel invasion o f HNSCC cell lines suggested that cell migration plays
an important role in the invasive process o f HNSCCs.

Proteolytic degradation o f the extracellular matrix is considered the rate-limiting
step in tumor invasion. M MPs are a group o f zinc dependent proteases responsible for
degradation o f extracellular matrix proteins. Studies in the past have shown that MMPs
are involved in local invasion and distant dissemination o f a variety o f tumors (38). Since
MMP-9 and MMP-2 are two well characterized MMPs, we assessed MMP-2/MMP-9
secretion into conditioned medium by gelatin zymography. HNSCC cell lines exhibited
differential levels o f M M P-2 activity. Densitometric analysis revealed that MMP-2
secretion was correlated with Matrigel invasion by HNSCC cell lines.

One notable

exception was EVSCC18 cells, which secreted high levels M M P-2 but were poorly

R e p ro d u c e d with perm ission of the copyright owner. Further reproduction prohibited without permission.

88

invasive. Further analysis showed that EVSCC18 cells were also weakly motile,
suggesting that the low invasive potential o f EVSCC18 was due to impaired motility. In
addition to MMP-2 secretion, HNSCC cell lines also secreted variable amounts o f MMP9. However, we found that MMP-9 secretion was not correlated with Matrigel invasion.
In contrast to our findings, other studies have demonstrated that MMP-9 production was
required for Matrigel invasion (57). These divergent results from different laboratories
likely reflect the heterogeneous nature of HNSCCs. Although our findings underscore
MMP-2 as a critical determinant o f in vitro invasion, they do not exclude a role for
MMP-9 in the pathogenesis o f HNSCC.

For example, MMP-9 may target substrates

other than Matrigel or may generate products that act as chemoattractants and thus
influence cell behavior.

Gelatin zymography detects the enzymatic activity that degrades gelatin
incorporated into a polyacrylamide gel. Therefore, the technique per se is not specific for
the

measurement

of

MMP-9/MMP-2.

Recently,

calcium-

and

zinc-independent

gelatinases were identified in human circulation that exhibited sim ilar mobilities to
MMP-9/MMP-2 in gelatin zymography (140) Thus, it is possible that gelatinase activity
detected by zymography was due to proteases other than MMP-9/MMP-2. To exclude
this possibility and to confirm the presence of MMP-2 in conditioned medium, samples
were analyzed by immunoblotting with anti-MMP-2 antibody. MMP-9 was not further
evaluated by this methodology.

Interestingly, the MMP-2 specific signals were only

detected in nonconcentrated conditioned medium from cell lines that secreted high levels
o f MMP-2 enzymatic activity; however, when CM was concentrated 10-fold, the results

R e p ro d u c e d with perm ission of th e copyright owner. Further reproduction prohibited without permission.

89

o f western blot analysis for MMP-2 protein correlated with results obtained by
zymography. Western blot analysis confirmed that HNSCC cell lines secreted MMP-2.
In addition, treatment o f CM with 50 mM EDTA abolished gelatinase activity, further
confirmation that the gelatinase activity detected in zymography was divalent cationdependent MMP-9/MMP-2. Taken together, the results demonstrated that western blot
analysis o f MMP-2 protein was less sensitive than enzymatic detection o f MMP-2 by
zymography.

Ir. addition to detection o f MMP-2 in conditioned medium, we also

analyzed the expression o f MMP-2 protein in cell lysates by western blot analysis. MMP2 expression in cell lysates was correlated with MMP-2 secretion in most cell lines except
FaDu and A 431. FaDu cells exhibited a high level o f M MP-2 in cell lysates, which was
barely detectable in CM. In contrast, A431 cells produced minimum MMP-2 in cell
lysates, yet exhibited high levels o f MMP-2 activity in CM. Different levels o f MMPs in
cell lysates and conditioned medium from specific cell lines may reflect differences in the
efficiency o f intracellular transport and secretion o f M M Ps into the culture medium.

There is ample evidence that the basement membrane is compromised in invasive
HNSCC. Using immunohistochemistry, a depletion o f type IV collagen and Iaminin in
the basement membrane has been linked to lymph node metastasis (141,142). In the
present study, we demonstrated that constitutive secretion o f MMP-2 was correlated with
invasive potential in 5 o f 6 HNSCC cell lines tested. The results were consistent with a
previous report which showed the association o f M M P-2 expression with invasive
behavior o f oral carcinoma in a limited number o f cell lines (77). In support o f these
findings, MMP-2 expression has been detected in vivo in small nests o f cells at the
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advancing tumor front o f oral carcinoma and the presence o f MMP-2 was related to
lymph node metastasis (143). However, several studies have demonstrated that MMP-2
present in carcinoma in vivo may derive from the tum or stroma rather than tumor cells.
MMP-2 immunoreactivity was found in the peripheral cell layer o f neoplastic islands but
M MP-2 mRNA expression was confined to fibroblasts (144,145) suggesting that tumor
cells may be capable o f utilizing MMPs produced by stromal cells to facilitate invasion.
Although a role for stromal cells in the production o f MMPs in vivo cannot be ignored,
the detection and identification o f authentic M M P-2 in epithelial HNSCC cell lines
argues strongly for MMP production by the tumor cell.

Degradation o f ECM is a highly controlled process and depends on the balance o f
MMPs and TIMPs. Up-regulation o f MMPs or down-regulation o f TIMPs tilts the
balance towards proteolytic degradation o f the ECM and promotes tumor invasion (13).
We have demonstrated that MMP-2 overexpression was associated with tumor cells o f
high invasive potential. Because TIMP-2 preferentially binds to and inhibits MMP-2. we
assessed TIMP-2 expression and secretion by HNSCC cell lines by western blot analysis
and reverse zymography. HNSCC cell lines exhibited different levels o f TIMP-2 activity
in CM as measured by reverse zymography which correlated with TIMP-2 protein levels
in CM detected by immunoblotting. Unlike M M P-2 secretion, we found no association
between TIMP-2 secretion and Matrigel invasion. TIMP-2 levels were not consistently
decreased in highly invasive HNSCC cells (EVSCC14M and EVSCC17M) nor increased
in weakly invasive lines (eg., EVSCC19M and UM SCC10A). Thus, our results support
the concept that up-regulation o f MMP-2 rather than down-regulation o f TIMP-2
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determines the invasive phenotype o f HNSCC cells. Similar findings were reported in
giant cell tumors o f bone (69). In contrast, reduced TIMP levels were associated with
prostate tumor cells (70).

Collectively, the data emphasize an imbalance o f secretion

between MMPs and TIMPs. which may be tumor-type dependent.

Cell attachment to extracellular matrix proteins represents the initial and crucial
step in the invasion process o f tumor cells (13). To further characterize the invasive
phenotype o f HNSCC cells, we assessed the ability o f HNSCC cells to adhere to ECM
proteins by an in vitro adhesion assay. HNSCC cell lines exhibited differential adhesion
to the ECM proteins fibronectin, laminin, and type IV collagen. Cell adhesion to ECM
proteins was dose dependent, suggesting that binding o f HNSCC cells to ECM proteins
was specific. Cell adhesion was correlated with Matrigel invasion in 4 o f 6 cell lines
tested. Highly invasive cell lines. EVSCC14M and EVSCC 17M. were highly adhesive
whereas weakly invasive ceil lines. EVSCC 18 and FaDu, were less adhesive. In contrast,
weakly invasive EVSCC 19M and UMSCC 10A cells exhibited elevated levels o f
adhesion to most ECM proteins, suggesting that cell adhesion to ECM proteins is
necessary but not sufficient for Matrigel invasion. Interestingly, we observed that
HNSCC cells were either adherent to all or none o f the ECM proteins evaluated. This
generalized adhesive property to ECM proteins found with HNSCC cells has also been
observed in other tumor cell types (25,146, 147). Although the mechanism(s) underlying
this all or none cell adhesive response to ECM proteins is currently unknown, one
possibility is that integrin receptors for ECM proteins may be upregulated in a subset o f
HNSCC. Enhanced expression o f integrin receptors on tumor cells would be expected to
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increase cell adhesion to ECM proteins and facilitate tumor cell migration and invasion.
In support o f this hypothesis, a recent study demonstrated that over-expression o f integrin
subunits a2 . a3 , a 5 , a 6 was correlated with tumor invasion and metastasis o f squamous
cell carcinoma o f the oral cavity (148). Since a subunits o f integrin are able to associated
randomly with (3 subunits in vivo, overexpressed a subunits resulted in the up-regulated
expression o f a number o f integrin receptors for ECM proteins, including fibronectin,
laminin, and type IV collagen tested in the present study (148). An alternative
explanation to account for the generalized increase in cell adhesion to ECM proteins by
specific tumor cells is based on the state o f integrin activation. Integrins exist in either
high or low affinity states with respect to their extracellular ligands. We speculate that
integrins are constitutively activated in specific HNSCC tumor cell lines thus enabling
the high affinity binding to a number o f different ECM proteins. The mechanistic basis
o f integrin activation is poorly understood. However, the activating process appears to be
regulated by Ras-related GTPases and their downstream effectors (149). In support of
this concept, a recent study has shown that the activated a llb p 3 integrin enhanced cell
adhesion and invasion o f human melanoma cells (150).

Clearly, further studies are

required to distinguish among the above possibilities.

Integrin mediated cell adhesion to the ECM is a complex process that occurs in
specialized structures termed focal contacts or focal adhesions.

At these adhesions,

integrins bind externally to ECM proteins and internally to cytoskeletal proteins. Studies
have shown that integrins can interact with same ECM protein and that an individual
integrin can recognize and bind to different ECM protein ligands (20). Another layer of
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complexity for integrin mediated cell-ECM interaction is the involvement o f integrins in
the activation o f signal transduction pathways. By interacting with ECM protein ligands,
integrins can sense molecular cues in the extracellular environment and transduce these
signals across the cell membrane into the nucleus via a variety o f signal transduction
pathways to m odulate cell behavior. In addition, one integrin can regulate the biological
function o f another integrin family member, a process referred to as integrin cross-talk,
the mechanistic basis o f which is unknown (20). Regardless o f the above complexities,
the central them e o f integrin-ECM interactions is the recognition o f short peptide
sequences within the large ECM protein. One well-characterized integrin recognition
sequence is arginine-glycine-aspartic acid (RGD). Studies with other tumor cell types
showed that m any integrin regulated biological events were RGD dependent e.g. cell
adhesion, spreading, migration and invasion (21).

Likewise, we demonstrated that the

RGD peptide inhibited HNSCC cell adhesion to fibronectin and laminin in a dosedependent manner, suggesting that cell adhesion to fibronectin and laminin was RGD
dependent. RGD peptide did not inhibit HNSCC cell adhesion to type IV collagen,
indicating that integrin binding to type IV collagen was mediated by sequences other than
RGD. In contrast to RGD, the control peptide, RGE, had no effect on cell adhesion to any
o f the ECM proteins. Thus, this single amino acid change completely abolished RGD
anti-adhesive activity. The results demonstrated that inhibition o f cell adhesion to
fibronectin and laminin by RGD peptide was specific. In addition, we also compared the
efficiency o f the RGD tripeptide with the peptide GRGDSP to block cell adhesion to
fibronectin. GRGD SP peptides were two-fold more efficient than RGD tripeptides,
suggesting that am ino acids adjacent to RGD increase the efficiency o f integrin-RGD
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interactions. Overall, our results are consistent with previous reports (30) and
demonstrate that cell adhesion to ECM proteins plays an important role in the invasive
process o f HNSCC cells.

In past decades, increasing interest has focused on deciphering the molecular
mechanisms underlying tumor invasion. It was proposed that tumor cell invasion consists
o f three sequential steps: cell adhesion, proteolytic degradation o f ECM proteins, and
chemoattractant directed migration. The proposed three-step hypothesis received
extensive experimental support and has elucidated molecular events related to each step
o f tumor invasion and subsequent metastasis formation (13). However, the step-wise
process o f invasion has not been tested systematically in the context o f HNSCCs. In the
present study, we first characterized the invasive phenotype o f six HNSCC cell lines by
measuring tumor cell invasion through a reconstituted basement membrane, cell adhesion
to

ECM

proteins,

MMP-2/MMP-9

production and cell

migration.

The results

demonstrated that high invasive HNSCC cell lines exhibited enhanced adhesion to ECM
proteins. MMP-2 production, and directed cell migration toward chemoattractants.
Defects in one or more o f these properties render the cell less or non-invasive.

Our

results demonstrate that the three-step model o f tumor invasion can be expanded to
include HNSCCs.

4.2 MMP-2 production is necessary for Matrigel invasion

The role o f M M Ps in tumor invasion has been clearly established (151). MMP-2,
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which cleaves basement membrane collagen, was the first member o f the
collagenase family to be closely linked with the invasive phenotype (152). Expression of
MMP-2 has been associated with tumor invasion and metastasis in many types o f
malignancy (38). However, the role o f MMP-2 in tumor cell invasion by HNSCCs was
not clearly established. We have demonstrated that over-expression o f MMP-2 rather
than down-regulation o f TIMP-2 tilted the balance towards ECM degradation and that
overexpression o f MMP-2 was associated with the in vitro invasive potential o f HNSCC
cell lines. Other studies showed that expression o f MMP-2 was correlated with lymph
node metastasis in oral squamous cell carcinoma (77). To provide more direct evidence
that MMP-2 production was necessary for, and not simply correlated with, the invasive
potential o f head and neck tumors cells, we demonstrated that antibody to MMP-2
blocked in vitro invasion o f HNSCC cell lines. However, inhibition of in vitro invasion
by anti-MMP-2 was inefficient.

Large doses o f MMP-2 antibody (100 ug/ml) were

required to achieve substantial inhibition, suggesting that even high concentrations o f
antibody were insufficient to neutralize excess MMP-2 secreted by the cell line.
Alternatively, HNSCC cells may secrete other proteases involved in Matrigel invasion.
In support o f our findings. Albini et al (74) showed that MMP-2 specific antibody
inhibited HT1080 tumor cell invasion to the same extent as TIMP-2. In addition, MMP-2
antibody inhibited HT1080 cell migration by 27% suggesting that the effect o f MMP-2
antibody on HT1080 cell invasion was partially mediated by blocking cell migration.
Inhibition o f cell migration by MMP-2 antibody supports recent evidence that MMPs are
not solely involved in the proteolytic digestion o f the ECM, but can also modify cell
attachment. Thus, MMP-2 antibody may inhibit cell migration by interfering with cell
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attachment and detachment mediated by membrane-MMP-2 (74). The role o f M M P-2 in
cell migration by HNSCC remains to be determined.

4.3 MMP production and cell migration is regulated bv integrin mediated cell-ECM
interaction

Cell adhesion to ECM proteins is the initial step in tumor invasion. It represents
the most direct cell-ECM interaction. Accumulating evidence has demonstrated the
importance o f ECM and the tissue microenvironment in tumor progression and metastasis
(153). Utilizing the nude m ouse model, we have shown previously that the site o f tum or
implantation, i.e., the tissue microenvironment, strongly affects tumor cell behavior and
invasion by HNSCCs (132).

In work described above, we demonstrated that cell

adhesion to ECM proteins is correlated with tumor invasion by HNSCC cells in vitro. In
this section, we discuss the evidence that cell-ECM interactions regulate M M P
production and cell migration in the context o f our understanding o f how these
interactions may regulate the invasive behavior o f HNSCC.

a. Regulation o f MMP production by cell-ECM interactions

MMPs are secreted as soluble, latent proenzymes that are activated by proteolytic
cleavage o f an amino-terminal domain. Thus, a clearer understanding o f MMP activation
is critical to defining the invasive tumor phenotype. In the previous section, we discussed
evidence showing that the extent o f proMMP-2 secretion was correlated with M atrigel
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invasion in 5 o f 6 HNSCC cell lines. One exception, EVSCC 18 cells, produced large
amounts o f proM M P-2 but the cells were poorly invasive suggesting that proM M P-2
secretion may be necessary but not sufficient for acquisition o f the invasive phenotype.
Previous studies have shown that only activated MMPs are able to digest the ECM (13).
Consistent with these findings, activated MMP-2 was linked to lymph node metastasis o f
oral carcinoma cells (154,155). However, in our study, non-stimulated HNSCC cells
produced barely detectable activated forms o f MMP-2 assessed by gelatin zymography.
To be functional, proM M P-2 m ust somehow be activated during the process o f Matrigel
invasion. Because cell-ECM interactions were demonstrated previously to stim ulate
MMP expression (22), we reasoned that ECM proteins might stimulate MMP-2 secretion
or activation by HNSCC cells. The experiments to test this hypothesis generated some
unexpected results (see Fig. 3-13 & 3-14). First, MMP-2 secretion and/or activation was
unaffected by fibronectin or laminin in three representative highly or weakly invasive
HNSCC cell lines.

Second, and unexpectedly, fibronectin stimulated secretion and

activation o f proM M P-9 in dose-dependent manner by each cell line.

Laminin also

stimulated MMP-9 production, but less potently and in only one o f the cell lines
suggesting that the effect o f laminin on MMP-9 secretion was cell line-specific. Cell
specific regulation o f MMP-9 by laminin is likely to reflect laminin receptor
heterogeneity in HNSCCs. We also observed that type IV collagen at low doses had no
effect on M MP-9/M MP-2 secretion, whereas higher doses (>40 ug/ml) inhibited
secretion o f MMP-9/M MP-2. A similar example o f suppression o f MMP secretion by
fibronectin and the a 4 p i integrin was reported in fibroblasts (156). Although the impact
o f negative signaling by ECM-integrins is poorly understood, it seems likely that integrin
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receptors and ECM ligands collaborate in vivo to regulate MMP expression in the context
of the tissue microenvironment. Because both MMP-2 and MMP-9 are known to digest
basement membrane constituents, we speculate that constitutive secretion o f MMP-2 may
be responsible for the initial breakdown o f the basement membrane in vivo and that
subsequent up-regulation and activation o f MMP-9 by cell-ECM interactions may
potentiate ECM degradation and tumor invasion.

Consistent with our findings, recent studies have shown that integrin-mediated
cell-ECM interactions influence MMP expression and/or activation. Type I collagen upregulated MMP-1 secretion in skin keratinocytes (157) and human osteosarcoma cells
(35). Similarly, fibronectin was shown to induce MMP-9 secretion in a variety o f cell
types including fibroblasts (158), macrophages (159), and ovarian carcinoma cell lines
(34).

In addition, other studies have shown that type I collagen induced MMP-2

activation in normal and malignant human fibroblastoid ceils (160), and laminin was
reported to stimulate MMP-2 activation in rhabdomyosarcoma cells (161).

Evidence from several laboratories has demonstrated that regulation o f MMPs by
ECM proteins is dependent on the expression o f integrin receptors. For example, crosslinking o f integrins with antibodies against p i and a3 integrins stimulated MMP-9
production in oral keratinocytes (162) and anti-a3 integrin resulted in MMP-2 activation
in rhabdomyosarcoma cells (161). Similarly, clustering o f the integrin ocv(}3 with antiintegrin antibody led to increased expression o f MMP-2 in melanoma cells (36).

In

addition, upregulation o f P3 integrin was associated with MMP-9 expression in
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melanoma cell tumors transplanted into nude mice (163). Although characterization o f
the integrin receptors in HNSCC cell lines is beyond the scope o f this work, it seems
reasonable to conclude that specific integrin engagement with ECM proteins induces
MMP-9 expression in head and neck tumor cells. Further studies are needed to uncover
the mechanisms responsible for fibronectin-induced activation o f MMP-9.

b. Cell-ECM interactions regulate cell motility o f HNSCCs

Cell-ECM interactions not only regulate MMP secretion but also modulate cell
migration. Accumulating evidence has demonstrated that ECM proteins are able to
stimulate locomotion in many types o f tumor cells including melanoma, glioma,
mesothelioma, fibrosarcoma, osteosarcoma, lung and breast carcinoma ( reviewed in 49).
The motility-stimulating ECM proteins include vitronectin, fibronectin. laminin, type I
collagen, type IV collagen and thrombospondin (49). In the previous section, we
discussed evidence showing that cell motility is an important determinant o f the invasive
phenotype o f HNSCCs. However, little is known about the effect o f ECM proteins on cell
migration by HNSCC cells.

In experiments aimed to determine the effect o f ECM

proteins on tumor cell migration (chemotaxis), we demonstrated that fibronectin, laminin,
or type IV collagen stimulated chemotaxis o f two highly invasive HNSCC cell lines over
a broad dose range, whereas these ECM proteins failed to stimulate chemotaxis of a
weakly invasive HNSCC cell line (see Figs. 3-16 to 3-18). Two observations emerged
from the results o f these experiments. One, the highly invasive cell lines exhibited high
motility in the absence o f exogenous stimulation by ECM proteins (so called
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chemokinesis). In the present study, we demonstrated high motility in highly invasive cell
lines even without stimulation. The mechanism underlying the enhanced m otility is not
clear. Interestingly, we have found that one o f the highly invasive cell

lines

(EVSCC 17M) has high levels o f EGF receptor expression by im munohistochemistry
(unpublished observations). Since EGF has been shown previously to stim ulate cell
migration by a variety o f tumor cell types, we speculate that the high endogenous m otility
seen in EVSCC 17M might be due to activation o f the EGFR signaling pathway. Indeed,
we have found that EGF receptor blocking antibody A225 inhibited cell m igration dosedependently (unpublished observations) suggesting the presence o f an EG F-EGFR
autocrine loop in EVSCC 17M cells resulting in high endogenous motility. Second, cell
migration in response to fibronectin and type IV collagen was biphasic.

Low and

intermediate doses stimulated whereas high doses reduced cell migration. The same
phenomenon has been observed in other tum or cell types without clear explanations (25).
One possibility is that high doses o f ECM proteins result in integrin internalization (164).
Temporary down regulation o f the integrin receptor may lead to reduced motility. Other
studies have shown that tumor cells have the ability to assemble fibronectin and the
assembled fibronectin polymer could inhibit cell migration (165). High doses o f
fibronectin may facilitate fibronectin assembly, thus inhibiting cell migration. Although
our results are unable to explain these observations, the findings demonstrate that cellECM protein interactions regulate chemotaxis by HNSCC cells.

We have shown that cell contacts with ECM proteins can modulate MMP
secretion and cell motility.

These cell-ECM interactions are mediated by integrin
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receptors.

Ligand binding and activation o f integrins is dependent on a peptide

recognition m otif (RGD) recognized by several members o f the integrin family (20). To
provide evidence that cell contact with fibronectin was integrin receptor dependent, we
demonstrated that synthetic RGD peptides specifically inhibited cell migration in
response to fibronectin. Previous studies have shown that RGD peptides can block cell
migration by specific ECM proteins in a variety o f tumor cells (166). Thus, our findings
support and extend earlier work and demonstrate that fibronectin-stimulated HNSCC
locomotion is RGD dependent and at least partially mediated by integrins. W hich integrin
receptors are involved in regulation o f HNSCC cell motility by ECM proteins is currently
unknown. Studies in the past have linked a6p4 and av p 6 to local invasion and metastasis
o f HNSCCs (167. 168). Recent studies demonstrated that expression o f a2. a 3 . a 5 . and
a 6 integrin subunits was correlated with tumor invasion and poor prognosis o f HNSCCs
(148). Collectively, the findings suggest that these integrins may be good candidates for
motility receptors. Further investigation is needed to identify and characterize integrin
receptors critical for HNSCC cell migration and their role in tum or cell invasion. In the
future, it may be possible to develop and clinically evaluate short peptide sequences (eg..
RGD-like) capable o f blocking tumor cell invasion.

4.4 Involvement o f calcium signaling in regulation o f the invasive phenotype o f HNSCCs

Intracellular calcium homeostasis is a common regulatory point in many signal
transduction pathways and is known to be essential for several biological process
including cell proliferation, angiogenesis. cell migration and invasion (88). To determine
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if calcium-signaling was important in HNSCC biology, we made use o f CAI. a novel
inhibitor o f calcium influx. CAI has been shown to inhibit cell adhesion, proliferation,
and cell migration in many cell types (126).

We demonstrated that CAI inhibited the invasiveness and motility o f HNSCC cell
lines in vitro, consistent with previous reports showing that CAI is an anti-metastatic
agent (126.169).

We also demonstrated that CAI inhibited both MMP-2 and MMP-9

production by HNSCC cells, indicating that calcium homeostasis is important in
regulation o f MMP secretion. This supports and extends previous studies showing that
CAI inhibits MMP-2 production by fibrosarcoma and endothelial cell lines (170.171).
Whether CAI

inhibits

the

production o f MMPs at

level o f transcription

or

translation/secretion in HNSCC is not clear. In a recent study. CAI was found to reduce
MMP-2 mRNA transcription (170). Further work is necessary to determine if CAI also
inhibits transcription o f M MPs in HNSCCs. The reduction o f MMP activity by CAI
suggests that inhibition o f the invasive potential o f HNSCCs also involves inhibition o f
MMP production.

We demonstrated that integrin mediated cell-ECM is important in regulating cell
migration and MMP production. Studies by others demonstrated that integrin receptorligand binding and activation leads to an influx o f intracellular calcium.

Our results

demonstrated that blocking calcium influx with CAI inhibited cell migration, MMP
production, and Matrigel invasion. Thus, our findings suggest that regulation o f cell
migration and MMP production by cell-ECM interactions is dependent on calcium

R e p ro d u c e d with permission of the copyright owner. Further reproduction prohibited without perm ission.

103

signaling and indicate that interruption o f calcium-dependent signaling pathways may
represent a useful strategy for the therapeutic management o f HNSCC.

4.5 FAK expression and activation is important in regulation o f the invasive phenotype o f
HNSCCs

A substantial body o f evidence has demonstrated a critical role for FAK in
integrin-mediated signaling (94, 96).

Moreover, increased FAK expression has been

proposed as a biom arker for invasive and metastatic tumors (105). Because the role o f
FAK in integrin-mediated signaling in HNSCC cells and the biological consequences o f
FAK expression and tyrosine phosphorylation have not been fully explored, we analyzed
FAK expression and phosphorylation in HNSCC cell lines. The results demonstrated that
HNSCC cell lines exhibited differential levels o f FAK protein and phosphorylated FAK.
FAK phosphorylation was correlated with cell migration and Matrigel invasion o f
HNSCCs, suggesting that FAK activation contributes to the invasive phenotype o f
HNSCCs.

To investigate whether FAK signaling has a causal role in the invasive phenotype
o f HNSCC, we overexpressed FAK in a weakly invasive HNSCC cell line, EVSCC 18.
The results demonstrated that forced expression o f FAK significantly stimulated MMP-9
production, cell migration towards chemoattractants (NIH3T3 conditioned medium or
fibronectin), and Matrigel invasion.

Consistent with these results, overexpression o f
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FAK in Chinese hamster ovary (CHO) cells stimulated migration towards fibronectin
(110). Thus, our results confirmed and extended earlier work and suggested that FAK
contributes in some way to the acquistion o f the invasive phenotype o f HNSCCs.

Although forced FAK expression significantly increased the in vitro invasive
potential o f weakly invasive EVSCC 18 cells, they never achieved the invasive potential
o f highly invasive cell lines, EVSCC 14M and EVSCC 17M. Thus, we conclude that FAK
overexpression is not sufficient for acquistion o f the invasive phenotype and that other
factors are needed for development o f the invasive and metastatic phenotype.

We

speculate that sub-cellular localization o f FAK and FAK-associated proteins to focal
contact sites are important determinants in promoting enhanced rates o f cell migration.
Further experiments are needed to address this possibility.

To further investigate the role o f FAK in the invasive phenotype, we sought to
inhibit FAK function in highly invasive cells by overexpression o f FRNK, an
alternatively spliced product o f the FAK gene, which is proposed to act as an in vivo
competitive inhibitor o f FAK (104).

Specifically, FRNK was transfected into highly

invasive EVSCC 14M cells, which expressed high levels o f FAK and phosphorylated
FAK. Subsequent analysis demonstrated that forced expression o f FRNK in EVSCC 14M
cells

slightly

inhibited

FAK

expression,

but

significantly

decreased

FAK

phosphorylation. Previous studies have shown that mouse fibroblasts derived from
FAK -/- knockout mice exhibited decreased rates o f cell migration in vitro relative to
cells from wild type mice (109) and that this migration defect could be rescued by
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transient FAK overexpression in FAK -/- cells (172). Moreover, transient overexpression
o f FRNK in Balb/3T3 fibroblasts and human endothelial cells reduced cell migration
(173) and stable overexpression o f FRNK blocked migration o f LNCaP prostate tumor
cells (174).

Therefore, the augmented invasive potential o f EVSCC 14M-FRNK

transfectants. manifested as increased migration. Matrigel invasion, and MMP-9
secretion, was unexpected and not in agreement with the above findings. In support o f
our findings, enhanced FAK phosphorylation was associated with decreased migration in
NIH3T3 fibroblasts and bovine endothelial cells and down modulation o f FAK
phosphorylation by expression o f a v-src kinase-negative mutant increased cell migration
(175).

Taken together with our findings, the data suggest that FAK activation is tightly

regulated and that increases or decreases in FAK phosphorylation modulate cell function.
Alternatively, our results support a model o f a dual integrin-mediated signaling pathway
in HNSCC cells that was reported previously in fibroblasts (176). In this model, both
FAK-dependent and FAK-independent mechanisms

for integrin-mediated

MAPK

activation and downstream signaling can occur. Our findings o f significantly decreased
FAK

phosphorylation

in

FRNK

overexpressors

suggest

that

integrin-mediated

downstream cellular functions can occur independent o f FAK function.

Finally, our results are compatible with a model in which FRNK overexpression
could trigger downstream events leading to altered gene expression such as cell
migration. Matrigel invasion, and MMP-9 secretion, as observed in EVSCC 14M-FRNK
transfectants.

FRNK lacks catalytic activity but contains three proline-rich domains

which interact with SH3 domains in target proteins, a tyrosine phosphorylation site
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(Tvr925). and a focal adhesion-targeting (FAT) domain responsible for targeting the
protein to focal adhesions (91.177).

We propose a model in which FRNK is

phosphorylated on Tyr925 by endogenous EVSCC 14M FAK; this leads to the
recruitment o f Grb-2 and SOS to Tyr925 via their SH2 domains and the formation of
signaling complexes which would be targeted to focal adhesions by FAT sequences in
FRNK and promote activation o f the Ras signal transduction pathway and downstream
cellular functions.

Support for this model derives from previous studies showing that

overexpression o f a kinase-defective FAK in CHO cells stimulated migration on
fibronectin (110). Although the underlying mechanisms by which FRNK overexpression
leads to augmentation o f the invasive phenotype o f HNSCC cells remain to be
investigated, our results demonstrate that the FAK signaling pathway has a critical role in
the modulation o f cellular determinants o f the invasive tumor cell phenotype.

In summary , evidence discussed in this section support the notion that FAKdependent signaling plays an important role in generating the invasive phenotype of
HNSCCs. Further investigation is required to dissect the signal transduction pathways
downstream o f FAK to clarify how FAK activation affects tumor cell invasion and
metastasis.
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CHAPTER V
SUM M ARY AND CONCLUSIONS

Local invasion and lymph node metastasis are predictive o f a poor clinical outcome
and the major obstacle to cure o f HNSCCs. A greater understanding o f the cellular and
molecular mechanism(s) underlying the invasive phenotype o f HNSCCs is expected to
translate into new therapeutic strategies. Utilizing a panel o f HNSCC cell lines previously
established in our laboratory, we sought to identify and characterize the cellular and
molecular determinants involved in the invasive process o f HNSCCs.

The invasive phenotype o f six HNSCC cell lines was analyzed by measuring tumor
cell invasion though a reconstituted basement membrane (Matrigel). cell adhesion to
ECM proteins. MMP-2/MMP-9 production and cell migration. The results demonstrated
that highly invasive HNSCC cell lines exhibited enhanced adhesion to ECM proteins,
increased MMP-2 production, and directed cell migration toward chemoattractants.
Defects in one or more o f these properties rendered tum or cells less or non-invasive. Our
results with HNSCC cells support a model o f tum or invasion that involves tumor cell
adhesion, ECM proteolysis, and cell migration.

In the process o f characterizing the invasive phenotype o f HNSCC cell lines, we
found that MMP-2 production was associated with Matrigel invasion. To provide more
direct evidence that MMP-2 production was necessary for, and not simply correlated
with, the invasive potential o f HNSCCs, we demonstrated that antibody to MMP-2
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blocked in vitro invasion o f the highiy invasive HNSCC cell line. EVSCC 14M, in a dose
dependent manner, confirming that MMP-2 was a necessary determinant o f invasive
potential.

Cell adhesion to ECM proteins is the initial step in tumor invasion and has
previously been shown in other tum or types to be important in the regulation o f other
steps o f the invasive process. We postulated that cell-ECM interactions might also be
important in modulating the invasive phenotype o f HNSCCs. To test this hypothesis.
HNSCC cells were exposed to soluble ECM proteins and measured for changes in cell
migration. MMP production and/or activation. ECM proteins (fibronectin. laminin. or
collagen type IV) stimulated cell migration o f highly invasive cell lines but failed to
stimulate migration o f a weakly invasive cell line. Fibronectin-stimulated cell migration
was specifically blocked by RGD peptides, a known recognition m otif for integrinfibronectin binding. Fibronectin also stimulated MMP-9 secretion and activation in a
dose-dependent manner by HNSCC cell lines but had minimal to no effect on MMP-2
secretion and/or activation. Laminin weakly and selectively stimulated MMP-9 secretion
but was without effect on MMP-2 secretion and/or activation. Collectively, our results
suggest that cell migration and M MP-9 production by HNSCC cells were regulated by
integrin-mediated cell-ECM interactions.

Integrin-mediated cell-ECM interactions are not only important in regulation o f a
variety o f biological process but are also responsible for the generation and transmission
o f signals across the cell membrane. Previous studies demonstrated that intracellular
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calcium was an important component o f the integrin-mediated signal transduction
pathways. Therefore, we sought to determine the role o f calcium signaling in the
regulation o f MMP secretion and generation o f the invasive phenotype o f HNSCCs.
Utilizing a novel calcium influx inhibitor, carboxyamido-triazole (CAI). we demonstrated
that inhibition o f calcium influx blocked cell motility, MMP-9/MMP-2 secretion, and
Matrigel invasion. Our findings suggest that calcium signaling plays an important role in
modulating the invasive phenotype o f HNSCCs.

FAK has been implicated in integrin-mediated signaling pathways and linked
previously to cell spreading, migration and invasion. To explore the role o f FAK in
integrin-mediated signaling in HNSCC cells and the biological consequences o f FAK
expression and activation, we analyzed FAK expression and phosphorylation in HNSCC
cell lines. The results demonstrated that FAK phosphorylation was correlated with cell
migration and Matrigel invasion o f HNSCCs, suggesting that FAK activation contributes
to the invasive phenotype o f HNSCCs.

To investigate whether FAK signaling has a

causal role in the invasive phenotype o f HNSCC, sense FAK or its negative regulator,
FAK-related non-kinase (FRNK), was expressed by stable transfection o f HNSCC cell
lines to assess the consequences o f FAK or FRNK transfection on the invasive
phenotype. Overexpression o f FAK in weakly invasive EVSCC 18 cells significantly
increased Matrigel invasion, MMP-9 production, and cell migration. Overexpression of
FRNK in highly invasive EVSCC 14M cells reduced FAK phosphorylation and
expression, but unexpectedly, enhanced Matrigel invasion, MMP-9 secretion, and cell
migration. Taken together, our findings suggest that the FAK signaling pathway has a
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critical role in the modulation o f cellular determinants o f the invasive tumor cell
phenotype.

In conclusion, data presented in the present study demonstrated that tumor cell
invasion in HNSCC is a complex process involving three repeated sequential steps:
adhesion, proteolytic degradation o f the basement membrane, and cell migration. These
three steps are linked and interdependent. For example, cell adhesion to ECM triggers a
series o f signal transduction pathways that involve calcium mobilization, focal adhesion
kinase activation and downstream events leading to alteration o f cell function manifested
by migration and MMP production. Our working model extends the previous three step
hypothesis o f tumor invasion by underscoreing FAK as an integrator o f multiple
signaling pathways. Efforts to determine the role o f FAK in the integration and
propagation o f signal transduction pathways should lead to a better understanding o f the
molecular mechanisms for generating the invasive phenotype o f HNSCCs, which may in
turn, lead to the discovery o f new targets for therapy o f invasive HNSCC. Identification
o f cellular and molecular determinants o f HNSCC may prove useful potentially as
biomarkers o f tumor cell behavior, prognosis, and for guiding treatment strategies.
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On behalf of the American Association for Cancer Research, me., as copyright owner of the
journal in which these works were originally published, I am pleased to extend to you the
requested permission contingent upon your obtaining the concurrence of the authors (If you are
not one). When reproducing these data, please include an appropriate citation acknowledging
our journal as the original source of the material.
Thank you for your interest in our pubfication.
Sincerely yours,

Margaret Foti, Ph.D.
Director of Publications
MF: jp
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Lewis Hall, P.O Box 100
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University o f Texas
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Box 179
Houston, TX 77030
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1993

Eastern Virginia Medical School
Department o f plastic Surgery
Microsurgical Fellow
Norfolk. Virginia

1990

Tongji Medical University
Department o f Orthopedic Surgery
Residency, Orthopedic surgery
Wuhan, China

Education:
1998

Old Dominion University
Eastern Virginia Medical School
Ph.D. Biomedical Science Program

1987

Tongji Medical University
M.S. in Orthopedic OncologyA joint program with orthopedic residency

1984

Tongji Medical University
Wuhan China
M.D.

Professional Activities:
Member o f Scientific Board, Association for Orthopedic
Research, Switzerland.

R e p ro d u c e d with permission of the copyright owner. Further reproduction prohibited without perm ission.

